Directed and coded oligonucleotides for combinatorial synthesis of coded probe molecules.

Encoded molecules with oligonucleotide structures facilitate efficient synthesis and identification of probe molecules that bind to targets, addressing inefficiencies in existing combinatorial library methods.

JP7587874B2Active Publication Date: 2024-11-21INSITRO INC
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
JP2023078674
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2016-06-16
Filing Date
2023-05-11
Publication Date
2024-11-21
Estimated Expiration
2037-06-08

AI Technical Summary

Technical Problem

Existing methods for synthesizing combinatorial libraries of molecules are limited by inefficient reaction steps, low copy numbers of probe molecules, and difficulty in detecting tight binding to target molecules, leading to false negatives and inefficient identification of molecules with desired properties.

Method used

The use of encoded molecules with specific structural formulations, including oligonucleotides and hairpin structures, allows for efficient synthesis and identification of probe molecules that can bind to target molecules, even in small numbers, through PCR amplification and hybridization arrays.

Benefits of technology

Enhances the efficiency of synthesizing and identifying probe molecules that bind to target molecules, overcoming limitations of low copy numbers and improving the accuracy of molecular identification.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007587874000001
    Figure 0007587874000001
  • Figure 0007587874000002
    Figure 0007587874000002
  • Figure 0007587874000003
    Figure 0007587874000003
Patent Text Reader

Abstract

To provide oligonucleotide directed and recorded combinatorial synthesis of encoded probe molecules.SOLUTION: The present disclosure relates to multifunctional molecules, including molecules according to formula (I): (I) ([(B1)M-D-L1]Y-H1)o-G-(H2-[L2-E-(B2)K]W)P, where G, H1, H2, D, E, B1, B2, M, K, L1, L2, O, P, Y, and W are defined herein. The present disclosure also relates to methods of preparing and using such multifunctional molecules to identify encoded molecules capable of binding target molecules.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] cross reference This application is a priority application of U.S. Provisional Application No. 62 / 351,046, filed June 16, 2017. No. 6,313,635, filed on Oct. 23, 2007, and which is incorporated herein by reference in its entirety. The present invention relates to multifunctional molecules and methods for preparing and using such multifunctional molecules. The present invention further relates to a method for the preparation of a medicament for use in ... pharmaceutical composition, comprising the steps of: binding to a target molecule, or exhibiting properties such as target molecule selectivity or cell permeability. Multifunctional molecules can be used to identify coding molecules that can have other desirable properties. The present invention provides a method for using the [Background technology]

[0002] There are three basic ways that molecules with desired functions, such as drugs, can be discovered: They are found in nature, rationally designed, and discovered by trial and error. While the trial-and-error approach is undoubtedly the most promising in many cases, it is surprisingly inefficient. The key to making the trial-and-error method more efficient is to To generate combinatorial libraries of molecules that are screened for their desired properties. The need to discover new molecules efficiently through trial and error has led to the development of combinatorial He gave birth to the field of experimental chemistry.

[0003] There are three major problems in synthesizing and testing combinatorial libraries. First, Many methods for preparing probe molecules from combinatorial libraries have been developed. The types and numbers of consecutive chemical subunits or building blocks that can be Second, many of the methods for assembling sequential building blocks are Third, in order to maintain efficiency, a huge number of processes must be It will be appreciated that the probe molecules must be simultaneously tested for the desired properties. A library with sufficient diversity of molecular shapes would contain only a few copies of any given molecule. It is also understood that low copy numbers can facilitate the identification of probe molecules with desired properties. Therefore, each probe molecule is unique enough to allow researchers to identify the desired probe molecule. Each device should be labeled with a unique identifier.

[0004] Researchers have developed DNA-encoded probe molecules to address some of these issues. Several researchers have developed template-based methods to direct one or more steps in combinatorial synthesis. Other researchers have used combinatorial synthesis to The probe molecules are then uniquely labeled with DNA oligonucleotides, and PCR (polymerase chain reaction) is then performed. Identify molecular probes that remain bound to the target molecule using nucleotide amplification (PCR) In addition, other researchers have used DNA oligonucleotides to Direct one or more steps of combinatorial synthesis and label probe molecules with unique identifiers. do.

[0005] Despite the success of many of these methods, some problems remain. Existing methods still suffer from the low efficiency of sequential reaction steps for synthesizing probe molecules. Existing methods also have the problem that they are difficult to produce probe molecules that tightly bind to target molecules. Difficult to detect, but present in small numbers. This difficulty can result in false negatives. It is possible to produce oligonucleotide probe molecules that increase the reaction efficiency of successive reaction steps. A method is needed to detect target molecules even if those probe molecules are present in low numbers. It is necessary to be able to identify the probe molecule that binds to the Summary of the Invention

[0006] The present disclosure relates to the encoded molecules. In certain embodiments, the encoded molecules are , a molecule according to formula (I). (I) ([(B1) M -D-L1] Y -H1) o -G-(H2-[L2-E-(B2) K ] W ) P Where: G is an oligonucleotide, the oligonucleotide comprising at least two coding regions and at least one terminal coding region, wherein at least two of the coding regions are single stranded. and at least one terminal coding region is single-stranded or double-stranded; H1 is a hairpin structure containing an oligonucleotide, and H1 terminates at the 5' end. It is bound to the end of the dinucleotide G; H2 is a hairpin structure containing an oligonucleotide, where H2 terminates at the 3' end. and attached to the end of oligonucleotide G; D is the first building block; E is a second building block, D and E are the same or different; B1 is a positional building block, and M is an integer from 1 to 20; B2 is a position building block, K represents an integer from 1 to 20, and B1 and B2 are are the same or different, M and K are the same or different; L1 is a linker operably linking H1 to D; L2 is a linker operably linking H2 to E; O is an integer from 0 to 1; P is an integer from 0 to 1; provided that at least one of O and P is 1; Y is an integer from 1 to 5; W is an integer from 1 to 5; At least one of the building blocks at each position, B1 at position M and B2 at position K, is a code. The first building block D and the second building block E are identified by one of the domains. At least one of the sequences of the block E has been identified by at least one terminal coding region.

[0007] In certain embodiments of the molecule of formula (I), G is of the formula (C N -(Z N -C N+1 ) A ) wherein C is a coding region, Z is a non-coding region, and N is 1. A is an integer between 1 and 20, and each non-coding region is 4 to 50 nucleotides long. In certain embodiments of the molecules of formula (I), the O or One of P is zero. In certain embodiments of the molecule of formula (I), at least one of Y and W is In certain embodiments of the molecule of formula (I), each coding region has 6 to 5 In certain embodiments of the molecule of formula (I), H1 and H2 each contain 0 nucleotides. At least one of them contains 20 to 90 nucleotides. In certain embodiments, each coding region comprises 12 to 40 nucleotides. In an embodiment, P is zero, Y is an integer from 1 to 2, and each coding region has 12 to 40 In certain embodiments of the molecules of formula (I), O is zero and W is 1 to 2, and each coding region contains 12 to 40 nucleotides.

[0008] The present disclosure relates to methods for identifying probe molecules capable of binding or selecting target molecules. and exposing the target molecule to a pool of probe molecules, the probe molecules having the formula (I) ) to remove at least one probe molecule that does not bind to the target molecule, and to obtain a copy sequence. At least one probe molecule that has not been removed from the target molecule forming Amplify one oligonucleotide G and copy at least one oligonucleotide of the sequence G to identify at least two coding regions of the probe molecule, and 1 and at least one of the building blocks B2 at position K is further identified, and then Identify at least one terminal coding region of the copy molecule and select a first build of the probe molecule. and further identifying at least one of the second building block D and the second building block E. can.

[0009] The present disclosure relates to methods of forming a molecule of formula (I). In certain embodiments, The method for forming the molecule of Providing at least one hybridization array, The hybridization array is immobilized on at least one hybridization array. at least one single stranded anticodon oligomer modified with at least one hybrid at least one single-stranded anticodon oligomer immobilized on a hybridization array; The sequence is capable of hybridizing to the coding region of a molecule of formula (II): (II) ([(B1) (M-1) -D-L1] Y -H1) O -G-(H2-[L2-E -(B2) (K-1) ]W ) P Where: G is an oligonucleotide, the oligonucleotide comprising at least two coding regions and at least one terminal coding region, wherein at least two of the coding regions are single stranded. and at least one terminal coding region is single-stranded or double-stranded; H1 is a hairpin structure containing an oligonucleotide, and H1 terminates at the 5' end. It is bound to the end of the dinucleotide G; H2 is a hairpin structure containing an oligonucleotide, where H2 terminates at the 3' end. and attached to the end of oligonucleotide G; D is the first building block; E is a second building block, D and E are the same or different; B1 is a positional building block, and M represents an integer from 1 to 20; B2 is a position building block, K represents an integer from 1 to 20, and B1 and B2 are are the same or different, M and K are the same or different; L1 is a linker operably linking H1 to D; L2 is a linker operably linking H2 to E; O is an integer from 0 to 1; P is an integer from 0 to 1; provided that at least one of O and P is 1; Y is an integer from 1 to 5; W is an integer from 1 to 5; and At least one of the building blocks B1 at position M and B2 at position K is a code. The first building block D and the second building block E are identified by one of the domains. at least one of the sequences of the sequence of the block E is identified by at least one terminal coding region; At least one strand immobilized on at least one hybridization array Hybridize the coding region of the subpool of molecules of formula (II) to the anticodon oligomer of the classifying the pool of molecules of formula (II) into subpools by filtering the pool; A subpool of molecules of formula (II) is isolated from at least one hybridization array. Discharge randomly into separate containers; providing at least one of building blocks B1 and B2; and Reacting at least one of the building blocks B1 and B2 with a molecule of formula (II) forming a subpool of molecules of formula (I): (I) ([(B1) M -D-L1] Y -H1) o -G-(H2-[L2-E-(B2) K ] W ) P Where: G is an oligonucleotide, the oligonucleotide comprising at least two coding regions and at least one terminal coding region, each coding region being single stranded and having at least one terminal coding region may be single-stranded or double-stranded; H1 is a hairpin structure containing an oligonucleotide, and H1 terminates at the 5' end. It is bound to the end of the dinucleotide G; H2 is a hairpin structure containing an oligonucleotide, where H2 terminates at the 3' end. and attached to the end of oligonucleotide G; D is the first building block; E is a second building block, D and E are the same or different; B1 is a positional building block, and M is an integer from 1 to 20; B2 is a position building block, K represents an integer from 1 to 20, and B1 and B2 are are the same or different, M and K are the same or different; L1 is a linker operably linking H1 to D; L2 is a linker operably linking H2 to E; O is an integer from 0 to 1; P is an integer from 0 to 1; provided that at least one of O and P is 1; Y is an integer from 1 to 5; W is an integer from 1 to 5; At least one of the building blocks at each position, B1 at position M and B2 at position K, is a code. The first building block D and the second building block E are identified by one of the domains. At least one of the sequences of the block E has been identified by at least one terminal coding region.

[0010] In certain embodiments of the method of forming a molecule of formula (I), the molecule of formula (II) is A pool of oligonucleotides is provided, said oligonucleotides G' being at least two and at least one terminal coding region, is single stranded, at least one terminal coding region is single stranded, and the oligonucleotide at least one of the terminal coding regions at the 5' and / or 3' ends of G' differs; Provide at least one charged carrier anticodon. and the at least one charge carrier anticodon has the formula ([(B1) (M-1) -D -L1] Y -H1) and / or (H2-[L2-E-(Β2) (K-1) ] W ) ; A pool of oligonucleotides G' and at least one charge carrier anticodon are combined. Mixture; Attaching the 5' end of at least one oligonucleotide G' to the 3' end of H1; and and / or at least one oligonucleotide G' having its 3' end linked to the 5' end of H2. to form a pool of molecules of formula (II): (II) ([(B1) (M-1) -D-L1] Y -H1) O -G-(H2-[L2-E -(B2) (K-1) ] W ) P G, H1, H2, D, E, B1, B2, L1, L2, O, P, Y and W are each represented by the above formula (I). where M and K are 1.

[0011] In certain embodiments of the method of forming a molecule of formula (I), the method comprises: I) by removing a portion of the oligonucleotide from at least one terminal coding region of the molecule In certain embodiments of the method of forming a molecule of formula (I), the method further comprises: The molecule of formula (I) further comprises at least one ligation of H1 to G and H2 to G. In certain embodiments of the method for forming a cycloalkyl group, G has the formula (C N -(Z N -C N+1 ) A )in wherein C is a coding region, Z is a non-coding region, and N is an integer from 1 to 20. and A is an integer from 1 to 20; each non-coding region is 4 to 50 nucleotides long. In certain embodiments of the method of forming a molecule of formula (I), the molecule comprises O or and P are 0. In certain embodiments of the method of forming a molecule of formula (I), Y and W At least one of is an integer from 1 to 2. Specific embodiments of the method for forming a molecule of formula (I) In this embodiment, at least one of H1 and H2 contains 20 to 90 nucleotides. In certain embodiments of the method for forming a molecule of the formula: or O is 0 and W is 1 to 2; is an integer, and each coding region contains 12 to 40 nucleotides. In certain embodiments, for example, the following items are provided: (Item 1) A molecule of formula (I) (I) ([(B1) M -D-L1] Y -H1) o -G-(H2-[L2-E-(B2) K ] W ) P Where: G is an oligonucleotide, the oligonucleotide comprising at least two coding regions and at least one terminal coding region, wherein at least two coding regions are single stranded and at least one terminal coding region is single stranded or double stranded; H1 is a hairpin structure containing an oligonucleotide, H1 terminates at the 5' end and is attached to the end of oligonucleotide G; H2 is a hairpin structure comprising an oligonucleotide, where H2 terminates at the 3' end and is attached to the end of oligonucleotide G; D is the first building block; E is a second building block, D and E are the same or different; B1 is a positional building block, and M is an integer from 1 to 20; B2 is a position building block, K represents an integer from 1 to 20, B1 and B2 are the same or different, and M and K are the same or different; L1 is a linker operably linking H1 to D; L2 is a linker operably linking H2 to E; O is an integer from 0 to 1; P is an integer from 0 to 1; provided that at least one of O and P is 1; Y is an integer from 1 to 5; W is an integer from 1 to 5; At least one of the position building blocks B1 at position M and B2 at position K is identified by one of the coding regions, and at least one of the first building block D and the second building block E is identified by at least one terminal coding region. (Item 2) G is a compound represented by the formula (C N -(Z N -C N+1 ) A 2. The molecule according to item 1, comprising a sequence represented by the formula: (Item 3) 3. The molecule according to any one of items 1 to 2, wherein one of O or P is zero. (Item 4) 4. The molecule according to any one of items 1 to 3, wherein at least one of Y and W is an integer of 1 to 2. (Item 5) 5. The molecule according to any one of items 1 to 4, wherein each coding region comprises 6 to 50 nucleotides. (Item 6) 6. The molecule according to any one of items 1 to 5, wherein at least one of H1 and H2 comprises 20 to 90 nucleotides. (Item 7) 7. The molecule according to any one of items 1 to 6, wherein each coding region comprises 12 to 40 nucleotides. (Item 8) 8. The molecule according to any one of items 1 to 7, wherein P is zero and Y is an integer from 1 to 2, and each coding region comprises from 12 to 40 nucleotides. (Item 9) 9. The molecule according to any one of items 1 to 8, wherein O is zero and W is an integer from 1 to 2, and each coding region comprises from 12 to 40 nucleotides. (Item 10) 1. A method for identifying a probe molecule capable of binding to or selecting a target molecule, comprising the steps of: exposing the target molecule to a pool of probe molecules, the probe molecules being as described in item 1; removing at least one probe molecule that does not bind to the target molecule; amplifying at least one oligonucleotide G from at least one probe molecule that was not removed from the target molecule forming a copy sequence; The sequence of at least one oligonucleotide G of the copy sequence can be determined to identify at least two coding regions of the probe molecule, and further identify at least one of the position building blocks B1 at position M and B2 at position K, and then at least one terminal coding region of the copy molecule can be identified, and further identify at least one of the first building block D and the second building block E of the probe molecule. (Item 11) A method of forming a molecule of formula (I), comprising: providing at least one hybridization array, said at least one hybridization array comprising at least one single-stranded anti-codon oligomer immobilized on the at least one hybridization array, wherein the at least one single-stranded anti-codon oligomer sequence immobilized on the at least one hybridization array is capable of hybridizing to a coding region of a molecule of formula (II): (II) ([(B1) (M-1) -D-L1] Y -H1) O -G-(H2-[L2-E-(B2) (K-1) ] W ) P Where: G is an oligonucleotide, the oligonucleotide comprising at least two coding regions and at least one terminal coding region, wherein at least two coding regions are single stranded and at least one terminal coding region is single stranded or double stranded; H1 is a hairpin structure containing an oligonucleotide, H1 terminates at the 5' end and is attached to the end of oligonucleotide G; H2 is a hairpin structure comprising an oligonucleotide, where H2 terminates at the 3' end and is attached to the end of oligonucleotide G; D is the first building block; E is a second building block, D and E are the same or different; B1 is a positional building block, and M represents an integer from 1 to 20; B2 is a position building block, K represents an integer from 1 to 20, B1 and B2 are the same or different, and M and K are the same or different; L1 is a linker operably linking H1 to D; L2 is a linker operably linking H2 to E; O is an integer from 0 to 1; P is an integer from 0 to 1; provided that at least one of O and P is 1; Y is an integer from 1 to 5; W is an integer from 1 to 5; and At least one of the building blocks B1 at position M and B2 at position K is identified by one of the coding regions, and at least one of the first building block D and the second building block E is identified by at least one terminal coding region; sorting the pool of molecules of formula (II) into subpools by hybridizing coding regions of the subpool of molecules of formula (II) to at least one single-stranded anticodon oligomer immobilized on at least one hybridization array; optionally releasing subpools of molecules of formula (II) from at least one hybridization array into separate containers; providing at least one of building blocks B1 and B2; and reacting at least one of building blocks B1 and B2 with a molecule of formula (II) to form a subpool of molecules of formula (I): (I) ([(B1) M -D-L1] Y -H1) o -G-(H2-[L2-E-(B2) K ] W ) P Where: G is an oligonucleotide, the oligonucleotide comprising at least two coding regions and at least one terminal coding region, each coding region being single stranded, and at least one terminal coding region being single stranded or double stranded; H1 is a hairpin structure containing an oligonucleotide, H1 terminates at the 5' end and is attached to the end of oligonucleotide G; H2 is a hairpin structure comprising an oligonucleotide, where H2 terminates at the 3' end and is attached to the end of oligonucleotide G; D is the first building block; E is a second building block, D and E are the same or different; B1 is a positional building block, and M is an integer from 1 to 20; B2 is a position building block, K represents an integer from 1 to 20, B1 and B2 are the same or different, and M and K are the same or different; L1 is a linker operably linking H1 to D; L2 is a linker operably linking H2 to E; O is an integer from 0 to 1; P is an integer from 0 to 1; provided that at least one of O and P is 1; Y is an integer from 1 to 5; W is an integer from 1 to 5; At least one of the position building blocks B1 at position M and B2 at position K is identified by one of the coding regions, and at least one of the first building block D and the second building block E is identified by at least one terminal coding region. (Item 12) Item 12. The method according to item 11, The molecule of formula (II) is providing a pool of oligonucleotides, said oligonucleotides G' comprising at least two coding regions and at least one terminal coding region, wherein at least two coding regions are single stranded and at least one terminal coding region is single stranded, and at least one terminal coding region at the 5' end and / or 3' end of the oligonucleotides G' differs; At least one charged carrier anticodon is provided, the at least one charged carrier anticodon having the formula ([(B1) (M-1) -D-L1] Y -H1) and / or (H2-[L2-E-(Β2) (K-1) ] W ) ; combining the pool of oligonucleotides G' with at least one charged carrier anticodon; by attaching the 5' end of at least one oligonucleotide G' to the 3' end of H1 and / or the 3' end of at least one oligonucleotide G' to the 5' end of H2 to form a pool of molecules of formula (II): (II) ([(B1) (M-1) -D-L1] Y -H1) O -G-(H2-[L2-E-(B2) (K-1) ] W ) P G, H1, H2, D, E, B1, B2, L1, L2, O, P, Y and W are as defined in formula (I) above, and M and K are 1. (Item 13) The method according to any one of items 11 to 12, The method further comprises removing a portion of the oligonucleotide from at least one terminal coding region of the molecule of Formula (I) or (II). (Item 14) The method according to any one of items 11 to 13, Further comprising at least one ligation of H1 to G and H2 to G. (Item 15) The method according to any one of items 11 to 14, G is the formula (C N -(Z N -C N+1 ) A ), wherein C is a coding region, Z is a non-coding region, N is an integer from 1 to 20, and A is an integer from 1 to 20; each non-coding region comprises 4 to 50 nucleotides and is optionally double-stranded. (Item 16) The method according to any one of items 11 to 15, Either O or P is zero. (Item 17) The method according to any one of items 11 to 16, At least one of Y and W is an integer of 1 or 2. (Item 18) The method according to any one of items 11 to 17, At least one of H1 and H2 contains 20 to 90 nucleotides. (Item 19) The method according to any one of items 11 to 18, P is zero and Y is an integer from 1 to 2, and each coding region contains from 12 to 40 nucleotides; or O is zero, W is an integer from 1 to 2, and each coding region contains from 12 to 40 nucleotides. [Brief description of the drawings]

[0012] The foregoing summary, as well as the following detailed description of the embodiments, is better read in conjunction with the accompanying drawings. It will be readily understood that, for purposes of illustration, certain preferred embodiments are shown in the drawings. It will be understood that the embodiments shown are not limited to the precise details shown.

[0013] [Figure 1] FIG. 1 illustrates an embodiment of a method for preparing a multifunctional molecule.

[0014] [Diagram 2] FIG. 2 is an illustration of an embodiment of a method for preparing multiple multifunctional molecules.

[0015] [Diagram 3] FIG. 3 is a flow diagram illustrating an embodiment of a method for forming a molecule of formula (I).

[0016] [Figure 4] FIG. 4 is a flow diagram illustrating an embodiment of a method for forming a molecule of formula (I). Detailed Description

[0017] All measurements are in standard metric units unless otherwise noted.

[0018] Unless otherwise noted, all instances of the words "a," "an," or "the" , may refer to one or more of the words they modify.

[0019] Unless otherwise noted, the phrase "at least one" means one or more than one object. For example, "at least one of H1 and H2" means H1, H2, or both. .

[0020] Unless otherwise noted, the term "about" refers to ±10% of a stated non-percentage number. and rounded to the nearest integer. For example, about 100 mm includes 90 to 110 mm. Unless otherwise noted, the term "about" means ±5% of a percentage. For example, about 20% means 1 5 to 25%, inclusive. When the term "about" is used in connection with a range, the term It refers to an appropriate amount that is less than the lower limit and more than the upper limit. For example, about 100 to about 200 mm , including 90 to 220 mm.

[0021] Unless otherwise noted, the terms "hybridize," "hybridize" and "hybridize" are used interchangeably. "Reduced" involves Watson-Crick base pairing and is a mechanism for DNA pairing with guanine -Cytosine and adenine-thymine (GC and AT), and guanine pairing in RNA -cytosine and adenine-uracil (GC and AU). Nucleotides for the nucleotides of the complementary strand, called the don or anticoding region Used in the context of selective recognition of strands.

[0022] "Selectively hybridize," "selective hybridization," and "selectively The term "select" refers to a sequence that is complementary to a non-complementary strand, with a ratio of 5:1 to 100:1 or more. It means strand selectivity.

[0023] The term "multifunctional molecule" refers to a molecule that is a combination of an oligonucleotide and at least one encoded By "amino acid" is meant a molecule of the present disclosure that comprises a moiety such as

[0024] The term "encoded portion" refers to a first building block, a second building block, , and a multi-functional block including only building blocks such as position building blocks B1 and B2. The term "encoded portion" refers to one or more portions of an encoded functional molecule. Although the moiety may be added as part of the synthesis process, it is not necessary to include a hairpin structure or a linker. Not at all.

[0025] The term "encoded molecule" refers to a molecule in which the encoded portion of a multifunctional molecule is Molecules that are likely to be formed or will be formed when removed or separated from the rest of the means...

[0026] The term "probe molecule" refers to a multifunctional molecule or an encoded portion of an encoded molecule. The molecule can bind to a target molecule or have a desired property such as target molecule selectivity or cell permeability. "Analytical" refers to a molecule used to determine whether a desired characteristic can be selected.

[0027] The term "target molecule" refers to a molecule or structure. For example, a structure may be a ribosome. These include multimacromolecular complexes and liposomes.

[0028] The term "probe molecule" can include multifunctional molecules.

[0029] The term "coded probe molecule" is used interchangeably with the term multifunctional molecule. I can.

[0030] The term "polydisplay" refers to a display that has at least two coded 1 shows a multifunctional molecule having a bonded moiety.

[0031] In this disclosure, a hyphen or dash in a molecular formula indicates that that part of the formula is a covalent bond or a halogen atom. It indicates that they are directly bonded to each other by hybridization.

[0032] Unless otherwise noted, all ranges of nucleotide and integer values ​​include all intermediate integers and For example, a range of 5 to 10 oligonucleotides includes 5, 6, 7, 8, 9, 10, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, , and 10 nucleotides.

[0033] In certain embodiments, the present disclosure provides a method for the preparation of a nucleic acid sequence comprising the steps of: For a polyfunctional molecule containing at least one coding portion, the oligonucleotide portion is Binatorial chemistry is used to direct or encode the synthesis of at least one coding portion. In certain embodiments, the oligonucleotide portion of the multifunctional molecule comprises at least one In certain embodiments, a single encoded portion can be identified. The functional molecule comprises a hairpin structure attached to at least one end of the multifunctional molecule, The ion structure allows for the polydisplay of multiple encoded moieties of multifunctional molecules. Without wishing to be bound by theory, polydisplay of multiple encoded portions may be The multifunctional molecules may be present in small numbers, at low concentrations, at low relative concentrations to other probe molecules, or in a mixture that exhibits the desired characteristics. The polyfunctional molecules of the present disclosure may be more effective as having desirable properties, even if they have a lower degree of affinity. In certain embodiments, the multifunctional molecule of the present disclosure comprises at least At least one oligonucleotide containing two more coding regions and at least one terminal coding region. It contains at least two coding regions and a small number of nucleotide or oligonucleotide segments. At least one terminal coding region is associated with the sequence of the building blocks of the encoded portion. Used to identify the sequences of the building blocks of the corresponding encoded portions In certain embodiments, at least one oligonucleotide or The oligonucleotide portion comprises at least one oligonucleotide or The original or copy can be amplified by PCR to generate copies of the gene portion. at least two coding regions and at least one terminal coding region of a multifunctional molecule In certain embodiments, the sequence is determined to determine the identity of at least two codons. The identity of the coding region and at least one of the terminal coding regions is determined by the PCR copy corresponding to the multiple functional group. A series of combinatorial chemical engineering techniques used to synthesize the encoded portions of functional molecules. This can be correlated with the degree of

[0034] In certain embodiments, the present disclosure provides methods for forming multifunctional molecules and for targeting molecules with multifunctional molecules. When exposed to a specific molecule, they have the ability to bind to one or more target molecules, or to other anti-target molecules. the property of not reacting with the enzyme, the property of being resistant to chemical changes formed by the enzyme, These include the properties of being easily chemically changed, being water soluble, and being cell permeable. To identify encoded portions, and thus encoded molecules, that exhibit desired properties, including but not limited to: This relates to a method for

[0035] In certain embodiments, the molecule of formula (I) is a polyfunctional molecule. In certain embodiments, G is an oligonucleotide that directs or selects for synthesis of the encoded portion. In certain embodiments of the molecule of formula (I), (B1) M -D and E -(B2) K Each represents an encoded moiety. In certain embodiments of the molecule of formula (I), In this embodiment, the molecule comprises an oligonucleotide portion and at least one coding portion. Many structural features of the oligonucleotide G are essential for their association with at least one of the molecules of formula (I). It is understood that the term is contemplated herein in that it directs or codes for the synthesis of the downloaded moiety. Many structural features of the oligonucleotide G of the molecule of formula (I) are To identify the synthetic steps used to prepare the oligonucleotide G or The ability of PCR to copy and thus generate the encoded portion of the molecule of formula (I) The sequences and / or identities of the building blocks and chemical reactions used are discussed. It is understood that.

[0036] In certain embodiments of the molecules of formula (I), G comprises an oligonucleotide or In certain embodiments, the oligonucleotide is a For example, about 50% to about 100%, and for example, about 90% to about 10 From about 1% to about 100%, including 0%, of the coding region is single-stranded. The oligonucleotide G contains at least one terminal coding region, and one or more of the terminal coding regions In certain embodiments, the oligonucleotide G has at least one terminal coding regions, one or two of which are double-stranded.

[0037] In certain embodiments of the molecules of formula (I), the oligonucleotide G has at least two covalent code regions, for example 2 to about 21 coding regions, for example 3 to 10 coding regions, for example 3 In certain embodiments, the number of coding regions is less than two. The number of possible code parts becomes too small to be practical. In certain embodiments, When the number of regions exceeds 20, synthesis inefficiencies prevent accurate synthesis.

[0038] In certain embodiments of the molecule of formula (I), the at least two coding regions are from about 6 to about 50 nucleotides, for example about 12 to about 40 nucleotides, for example about 8 to about 30 nucleotides. In certain embodiments, the coding region comprises less than about 6 nucleotides. In some cases, the coding region cannot precisely direct the synthesis of the encoded portion. However, if the coding region contains more than about 50 nucleotides, the coding region becomes cross-reactive. Such cross-reactivity may be due to the need to use a nucleic acid sequence that is encoded by a molecule of formula (I) This interferes with the ability of the coding region to precisely direct and identify the synthetic steps that are to be used.

[0039] In certain embodiments of the molecule of formula (I), the purpose of the oligonucleotide G is to obtain a complementary amplicon By selectively hybridizing to the nucleotide sequence of at least one molecule of formula (I), In certain embodiments, the coding region is single-stranded to promote hybridization with a complementary strand. So, 70%-100%, say 80%-99%, say 80%-95%, of the coding region The complementary strand for the coding region, if present, is a single stranded molecule of formula (I) during synthesis. It is understood that the encoded portion of may be added after the encoding step.

[0040] In certain embodiments, the oligonucleotides comprise natural and unnatural nucleotides. Suitable nucleotides include adenine (A), guanine (G), and cytosine ( C), and the natural nucleotides of DNA (deoxyribonucleic acid), including thymine (T); The natural nucleotides of RNA (ribonucleic acid): adenine (A), uracil (U), and guanine Other suitable bases include deoxyadenosine (G), cytosine (C), and cytosine (C). , deoxythymidine, deoxyguanosine, deoxycytidine, inosine, diaminopurine Natural bases such as 2-aminoadenosine, 2-thiothymidine, inosine, pyrrolo -pyrimidine, 3-methyladenosine, C5-propionylcytidine, C5-propionyl Uridine, C5-bromouridine, C5-fluorouridine, C5-iodouridine, C5-Methylcytidine, 7-Deazaadenosine, 7-Deazaguanosine, 8-Oxoadenosine Guanosine, 8-oxoguanosine, O(6)-methylguanine, 4-((3-(2-(2- (3-aminopropoxy)ethoxy)propyl)amino)pyrimidin-2(1H)-one , 4-amino-5-(hepta-1,5-diyn-1-yl)pyrimidin-2(1H)-o 6-Methyl-3,7-dihydro-2H-pyrrolo[2,3-d]pyrimidin-2-one , 3H-benzo[b]pyrimido[4,5-e][1,4]oxazine-2(10H)-o base derivatives such as cytidine and 2-thiocytidine; 2'-O-methylated bases and 2'-fluoro salts Modified nucleotides, such as 2'-substituted nucleotides containing the ribosomal group; 2'-fluororibose, ribosomal modified sugars such as saccharides, 2'-deoxyribose, arabinose, hexose; and / or phosphosaccharides; Modified phosphate groups include phosphorothioate and 5'-N-phosphoramidite linkages. It is understood that a oligonucleotide is a polymer of nucleotides. The term "polymer" and "oligomer" are used interchangeably herein. In certain embodiments, an oligomer An oligonucleotide does not have to contain consecutive bases. The oxidases may be interspersed in the linker moiety or in the non-nucleotide molecule.

[0041] In certain embodiments of the molecule of formula (I), the oligonucleotide G is about 60% to 100% , for example, about 80% to 99%, for example, about 80% to 95%, of DNA nucleotides. In certain embodiments, the oligonucleotide is about 60% to 100%, for example about 80% It comprises about 99%, for example about 80% to 95%, of RNA nucleotides.

[0042] In certain embodiments of the molecules of formula (I), the oligonucleotide G comprises at least two The overlapping coding regions include about 30% to 1%, e.g., about 20% to 1% of the same nucleotides. If only 1%, say about 10% to 2%, is shared, then at least two of the coding regions above In certain embodiments of the molecule of formula (I), the terminal codes Excluding the dot region, the oligonucleotide G is about 40% to 100%, for example about 60% to 10 0%, for example about 80% to 100%, are single-stranded. In the present invention, oligonucleotide G contains at least two coding regions, and at least one of the coding regions is In certain embodiments of the molecule of formula (I), the oligonucleotide G is at least two coding regions, the at least two coding regions being of a molecule of formula (I) They are separated by regions of nucleotides that do not direct or record the synthesis of the encoded portion. do.

[0043] The term "non-coding region" refers, if present, to the coded portion of a molecule of formula (I). incapable of hybridizing to a complementary strand of nucleotides to direct synthesis, or Any anti-coding oligonucleotide used to select the molecule of formula (I) during synthesis may be used. In certain embodiments, the term "nucleotide sequence" refers to a region of an oligonucleotide that does not correspond to a specific nucleotide. In certain embodiments, the oligonucleotide comprises 1 to about 20 non-coding regions, for example, 2 to about 9 non-coding regions, for example, 2 to about 4 non-coding regions In certain embodiments, the non-coding region comprises from about 4 to about 50 nucleotides, e.g. It comprises from about 12 to about 40 nucleotides, for example, from about 8 to about 30 nucleotides.

[0044] In certain embodiments of the molecules of formula (I), one purpose of the non-coding regions is to separate the coding region. The purpose of the present invention is to prevent or reduce cross-hybridization by separating the This is because cleavage of the carboxyl group prevents accurate encoding of the encoded portion of the molecule of formula (I). In certain embodiments, one purpose of the non-coding region is to simply hybridize to the molecule of formula (I). In certain embodiments, the addition of functionality other than redization or coding is preferred. In one embodiment, one or more of the non-coding regions may be an oligonucleotide modified with a label, such as a fluorescent label or a radioactive label. Such a label may be in the region of a nucleotide. Such a label may be useful for visualization or quantification of the molecule of formula (I). In certain embodiments, one or more non-coding regions can facilitate processing. In certain embodiments, one or more non-coding regions are modified with functional groups or tethers that facilitate In certain embodiments, the region is double-stranded to reduce cross-hybridization. It is understood that the non-coding regions are optional. In certain embodiments, suitable non-coding regions include , does not interfere with PCR amplification of the oligonucleotide.

[0045] In certain embodiments, one or more of the coding regions or terminal coding regions are fluorescently or radioactively labeled. It may also be a region of the oligonucleotide G that is modified with a label, such as a label. The label can facilitate visualization or quantification of the molecule of formula (I). In the present invention, one or more of the coding regions or terminal coding regions may be provided with a functional group or tether that facilitates processing. Be qualified.

[0046] In certain embodiments of the molecule of formula (I), G is of the formula (CN -(Z N -C N+1 ) A )(formula In the above, C is a coding region, Z is a non-coding region, N is an integer from 1 to 20, and A is In a specific embodiment, the sequence is represented by about 70% to 100 %, for example about 80% to 99%, for example about 80% to 95%, of the non-coding regions are 4 to 50 In a particular embodiment, about 70% to 100%, for example about 8, Between 0% and 99%, for example about 80% to 95%, of the non-coding regions are double-stranded.

[0047] In certain embodiments of the molecules of formula (I), the oligonucleotide comprises at least one In certain embodiments, the terminal coding region comprises, for example, one or two terminal coding regions. It is a sequence of nucleotides that is not directly linked to the amino acid structure and terminates at the 5' or 3' end. In certain embodiments, the terminal coding region comprises a sequence of nucleotides directly attached to the hairpin structure. Even if both ends of the oligonucleotide are connected by a hairpin structure, Oligonucleotides are oriented in 5' and 3' directions based on the basic geometric arrangement of nucleotides. It is understood that

[0048] In certain embodiments, one purpose of the terminal coding region is to facilitate the synthesis of an oligonucleotide during the synthesis of a molecule of Formula (I). Selective hybridization of hairpin structures containing complementary sequences to the ends of oligonucleotides. In certain embodiments, the terminal coding region is about 6 to about 50 nucleotides, for example, about 12 to about 40 nucleotides, for example, about 8 to about 30 nucleotides In certain embodiments, when the terminal coding region comprises less than about 6 nucleotides, As a result, the number of available, non-cross-reactive sequences is too low and the encoded portion of the molecule of formula (I) In certain embodiments, the terminal coding region is about 50 or more nucleotides long, which interferes with the accurate coding of the gene. When the nucleic acid sequence contains a nucleotide, the terminal coding region becomes cross-reactive and selects for only one hairpin structure. It is possible to lose too much specificity by selectively hybridizing to such a Cross-reactivity is due to the attachment of the first building block D and / or the second building block E. This would interfere with the ability of the coding region to accurately encode the addition of In certain embodiments, the terminal coding region is single-stranded or double-stranded.

[0049] In certain embodiments of the molecule of Formula (I), H1 and H2 each independently represent a hairpin structure. The term "hairpin structure" as used in the present disclosure means 60% by mass to 10 0% by mass of nucleotides, and the terminal coding region of oligonucleotide G In certain embodiments of the hairpin structure, the hairpin structure can hybridize to the The structure forms a single continuous polymer chain with at least one overlapping portion (commonly known as a "stem"). "), and the overlapping portion hybridizes to the complementary sequence of the same hairpin structure. In a particular embodiment of the hairpin structure, the bridge structure comprises two The bridge structure is linked to a separate oligonucleotide chain of 2 to 20 PEG units. PEG having 3 to 15 PEG units, for example 6 to 12 PEG units. In certain embodiments of the hairpin structure, the hairpin structure may include a PEG polymer. The cross-linked structure is composed of an alkane chain having up to 30 carbon atoms or a polyglycine chain having up to 20 units. or may consist of other chains carrying reactive functional groups. In an embodiment, the overlapping portions of H1 and / or H2 are the terminal ends of oligonucleotide G. In certain embodiments, H1 and H2 are each independently Each loop may contain one, two, three or four loops.

[0050] In certain embodiments of the molecule of Formula (I), H1 and H2 each independently represent about 20 to about 50 About 90 nucleotides, for example, about 32 to about 80 nucleotides, for example, about 45 to about 80 nucleotides In certain embodiments, H1 and H2 are each independently 1,2, 3, 4, 5, 6, 7, 8, 9 or 10, for example 1 to 5, for example 2 to 4, for example 2 to 3, a linker molecule or, optionally, a suitable compound for facilitating reaction with a building block. The nucleotides are each independently a 5'-diaminophenyl ester, ... Toxyltrityl-5-ethynyl-2'-deoxyuridine, 3'-[(2-cyanoethyl )-(N,N-diisopropyl)]-phosphoramidite (5-ethynyl-dU-CE phosphoramidite) Also known as holamidite, purchased from Glen Research, Sterling VA. This includes, but is not limited to, synthesis using bases such as these. In the embodiment, H1 and H2 are each independently a linker molecule or optionally a building block. The present invention provides a method for the preparation of a nucleotide sequence that is capable of reacting with ... However, 3-dimethoxytrityloxy-2-(3-(5-hexylamide) Propanamidopropyl-1-O-[(2-phenylpropanamide) (N,N-diisopropyl)-phosphoramidite (alkyne-modified Also known as fluorescerinol phosphoramidite, Glen Research, Ster Alkyne CEP (purchased from Goettier VA) and abasic alkyne CEP (IBA GmbH, Goettier In certain embodiments, H1 and H2 are each independently It includes nucleotides having modified bases already carrying linkers, e.g., H1 and H Each of 2 is independently selected from, but not limited to, 5'-dimethoxytrityl-N6-benzoyl -N8-[6-(trifluoroacetylamino)-hex-1-yl]-8-amino-2 '-Deoxyadenosine-3'-[(2-cyanoethyl)-(N,N-diisopropyl) ]-phosphoramidite (also known as the amino modifier C6dA, Glen Research , purchased from Sterling VA), 5'-dimethoxytrityl-5-[3-methyl- acrylate]-2'-deoxyuridine, 3'-(2-cyanoethyl)-(N,N-di isopropyl)]-phosphoramidite (also called Carboxy dT, Glen R purchased from research, Sterling VA), 5'-dimethoxytrityl-5- [N-((9-fluorenylmethoxycarbonyl)-aminohexyl)-3-acylimine 2'-Deoxyuridine, 3'-[(2-cyanoethyl)-(N,N-diisopropyl) pyril)]-phosphoramidite (also called Fmoc-amino modifier C6dT, Glen Research, Sterling, VA), 5'-dimethoxytrityl-5-(octyl ter-1,7-diynyl)-2'-deoxyuridine, 3'-[(2-cyanoethyl)-( N,N-diisopropyl)]-phosphoramidite (also called C8 alkyne dT, Gle n Research, Sterling, VA), 5'-(4,4'-dimethoxytri N-(6-(3-benzoylthiopropanoyl)-aminohexyl)-5-[N-(6-(3-benzoylthiopropanoyl)-aminohexyl)-3 -acrylamido]-2'-deoxyuridine, 3'-[(2-cyanoethyl)-(N, N-diisopropyl)]-phosphoramidite (also known as S-Bz-thiol modifier C6-dT) (Glen Research, Sterling VA), and 5-carboxy dC CEP (from IBA GmbH, Goettingen, Germany), N 4-TriG1-amino 2'-deoxycytidine (IBA GmbH, Goettinge n, from Germany). Modified nucleotides and non-nucleotides in H1 and H2 Suitable functional groups for the oxidase include, but are not limited to, primary amines, secondary amines, and the like. , carboxylic acids, primary alcohols, esters, thiols, isocyanates, chloroformates esters, sulfonyl chlorides, thiocarbonates, heteroaryl halides, aldehydes, chloro aryl halides, boronic acids, alkynes, azides, and Contains alkenes.

[0051] In certain embodiments, one or more of the hairpin structures H1 and H2 are fluorescently or radioactively labeled. Such labels can be used to visualize or quantitate the molecules of formula (I). In certain embodiments, one or more of the hairpin structures H1 and H2 can be , modified with functional groups or tethers that facilitate processing.

[0052] In certain embodiments of the molecules of formula (I), the advantage of the hairpin structure of H1 and H2 is that Either or both of the molecules of formula (I) may be polynucleotides having multiple encoded moieties at one or both ends of the molecule. Without wishing to be bound by theory, the present disclosure Polydisplay of multiple encoded moieties at one or both ends of a multifunctional molecule of It is believed to provide improved selectivity under certain conditions.

[0053] In certain embodiments of the molecule of Formula (I), Y and W are each independently 1, 2, 3, In certain embodiments, when O is zero, W is an integer from 2 to 5. For example, 2, 3, 4, or 5. In certain embodiments, when P is zero, Y is an integer from 2 to 5, for example, 2, 3, 4 or 5. In certain embodiments, O and When P is 1, W and Y are each independently an integer of 1 to 5, for example, 1, 2 In certain embodiments, W and Y are each independently selected from the group consisting of the formula (I is a measure or index of the polydisplay of the encoded portion of a molecule of Minutes are (B1) M -D and E-(B2) K Generally, the sum of Y and W is understood to be The higher the metric value, the higher the polydisplay of the molecules of formula (I).

[0054] In certain embodiments of the molecule of formula (I), D is the first building block. In embodiments, when D is present, D is located in the terminal coding region of G that is directly linked to H1. In certain embodiments, the G closest to the D is The terminal coding region corresponds to and is used to identify the first building block D. It is possible.

[0055] In certain embodiments of the molecules of formula (I), E is a second building block. In certain embodiments, when E is present, E is the terminal coding region of G that is directly linked to H2. In certain embodiments, the region located closest to E The terminal coding region of G corresponds to and is used to identify the first building block E. In certain embodiments, the first building block and the second building block may be used. The building blocks may be the same or different. Two building blocks are understood to be both building blocks.

[0056] In certain embodiments of the molecules of formula (I), B represents a positional building block. As used in this disclosure, the term "positional building block" refers to a molecule that forms a larger molecule. One of a series of individual building block units linked together as a single subunit In a particular embodiment, (B1) M and (B2) K are independent of each other and a series of individual buildings that combine to form a polymer chain having M and K units. For example, if M is 10, then (B) 10 Is Billy Block unit: B 10 -B9-B8-B7-B6-B5-B4-B3-B2-B1 For example, when M is 3 and K is 2, formula (I) is represented by the following formula: It can be expressed precisely.

[0057] ([((B1)3-(B1)2-(B1)1-D-L1] Y -H1) O -G-(H2-[ L2-E-(B2)1-(B2)2] W ) P

[0058] M and K each independently serve as a location identifier for an individual unit of B. is understood.

[0059] The precise definition of the term "building block" in this disclosure depends on the context. A "building block" is a chemical structure that can be chemically bonded to other chemical structural units. In certain embodiments, the building block is a building block. One, two or more chemical units capable of undergoing chemical reactions that link the cyclic alkyl group to other chemical structural units. When the building blocks undergo a reaction that forms a chemical bond, It is understood that some or all of the reactive chemical groups of the building blocks may be lost. For example, a building block in solution may have two reactive chemical groups. In this example, the building blocks in solution are separated into parts of the chain of building blocks. Reactions with reactive chemical groups on building blocks to increase chain length or to separate chains The branch can be expanded from the building block. When referring to a building block, it is understood that the building block comprises at least one reactive chemical group. Although the building blocks may be one or more reactive chemical groups, When referring to a polymer, oligomer or molecule larger than a block by itself, The building blocks are the units that make up the (monomer) structures of larger molecules. It is understood that the larger molecule may have one or more chemically reactive groups, even if one or more of the chemically reactive groups are reacted. It is.

[0060] The types of molecules or compounds that can be used as building blocks are A building block reacts with another building block to form a covalent bond Generally, the present invention is not limited to the above. In certain embodiments, the building blocks are In certain embodiments, the builder has one chemically reactive group that functions as a terminal unit. The binding block may have 1, 2, 3, 4, 5 or 6 suitable reactive chemical groups. In an embodiment, a first building block D, a second building block E, and B The position building blocks can be independently selected from 1, 2, 3, 4, 5 or 6 suitable positions. Suitable reactive chemical groups for building blocks include primary amines, Amines, secondary amines, carboxylic acids, primary alcohols, esters, thiols, isocyanates esters, chloroformates, sulfonyl chlorides, thiocarbonates, halogenated heptanes, Aryl, aldehyde, haloacetate, aryl halide, azide, halide , triflates, dienes, dienophiles, boronic acids, alkynes, and alkenes. do.

[0061] Any coupling chemistry is compatible with the presence of oligonucleotides. Chemistry can be used to attach the building blocks. Exemplary coupling chemistries include The method involves coupling amines, such as DNA-linked amines, to Fmoc-protected amino acids or other variously substituted carboxyl groups. Formation of amides by reaction with carboxylic acids; isocyanates and amines, including DNA-binding amines. and reaction with other amines to form urea (ureation); Roloformates (carbamoylation) and reaction with alcohols to form carbamates; Reaction of amines, including DNA-binding amines, with sulfonyl chlorides to form sulfonamides; Thiocarbonates by reaction of amines, including DNA-binding amines, with thionocarbonates and other amines. Urea formation (thioureation); halogenated heteroaryl amines, including DNA-binding amines. Formation of anilines by reaction with SNAr; amines and aldehydes, including DNA-binding amines Reaction with hydrides followed by reduction to form secondary amines (reductive amination); DNA-linked amines Acylation of an amine containing an amine with a chloroacetate followed by displacement of the chloride with another amine Formation of peptoids by SN2 reaction; aryl halide-substituted carboxylic acid Acylation of amines, including DNA-binding amines, followed by halogenation with substituted alkynes Substitution of aryl halides to form alkyne-containing compounds (Sonogashira reaction); Acylation of amines containing DNA-binding amines with substituted boronic acids. Formation of biaryl compounds by substitution of halogenides (Suzuki reaction); including DNA-binding amines. Reaction of an amine with cyanuric chloride followed by reaction with another amine, a phenol or a thiol ( Formation of substituted triazines by cyanurylation (aromatic substitution) Synthesis of D with carboxylic acids substituted with suitable leaving groups such as halides or triflates Acylation of an amine, including the NA-bound amine, followed by displacement of the leaving group by another amine (SN2 / SN1 reaction) to form a secondary amine; and catalyzing the amine with an alkene or alkyne by displacing the compound and reacting the product with an azide or an alkene (Diehl The formation of cyclic compounds through the s-Alder and Huisgen reactions is one example of the reaction. In certain embodiments, primary amines, secondary amines, carboxylic acids, primary alcohols, ethylene glycols, ethylene glycol-based amine ... Sulfonyl chloride, thiol, isocyanate, chloroformate, sulfonyl chloride, thiocarbonate acetates, heteroaryl halides, aldehydes, chloroacetates, aryl halides Molecules that react with amino groups, including alkenes, halides, boronic acids, alkynes, and alkenes The molecule has a molecular weight of about 30 to about 330 daltons.

[0062] In certain embodiments of the coupling reaction, amines, thiols, halides, boronic acids Molecules that have a second reactive group, such as an alkyne or alkene, that can be used in any of the above chemical reactions. Either of these can be used to convert the first building block to a DNA-binding amine by replacing it with an amine that contains the DNA-binding amine. A second reactive group may then be added to the carboxyl group of the carboxyl group having the appropriate reactive group. Exemplary second reactive group couplings include The coupling chemistry involves acylation of amines, including DNA-linked amines, with Fmoc-amino acids. followed by removal of the protecting groups and catalysis of the newly deprotected aldehyde with an aldehyde and a borohydride. Reductive amination of amines; the synthesis of amines containing DNA-binding amines with aldehydes and borohydrides. Reductive amination of the thiol followed by reaction of the now substituted amine with cyanuric chloride. Displacement of the triazine with another chloride by an amine, phenol, or another amine; DNA-binding amine Acylation of amines containing aryl groups with haloaryl-substituted carboxylic acids, followed by Displacement of the halide by SNAr reaction with another amine or thiol, and reaction with an aniline or thiol. Formation of ethers; DNA-binding amine-containing amines with haloaromatic substituted carboxylic acids acylation of amines followed by displacement of halides with alkynes in the Sonogashira reaction; or and substitution of halides with aryl groups in phosphate-mediated Suzuki reactions. .

[0063] In certain embodiments, the coupling chemistry is based on suitable bond-forming reactions known to those of skill in the art. For example, March, Advanced Organic Chemistry, orth edition, New York: John Wiley and Son. s(1992), Chapters 10 to 16; Carey and Sund berg, Advanced Organic Chemistry, Part B, P lenum (1990), Chapters 1-11; and Coltman et al. l.,Principles and Applications of Organo transition Metal Chemistry, University S science Books, Mill Valley, Calif. (1987), Ch. apters 13-20; each of which is incorporated herein by reference in its entirety. can be.

[0064] In certain embodiments, the building block is provided with a carboxyl group that is used to attach the building block. The compound may contain one or more functional groups in addition to the reactive group or groups used for the synthesis of the compound. One or more of these additional functional groups may be added to prevent undesired reactions of these functional groups. Suitable protecting groups are known to those skilled in the art for various functional groups (G reene and Wuts, Protective Groups in Orga nic Synthesis, second edition, New York:Jo Wiley and Sons (1991), the entirety of which is incorporated herein by reference. Particularly useful protecting groups include t-butyl esters and ethers, acetals, and phenyl ethers. trityl ethers and amines, acetyl esters, trimethylsilyl ether ... Chloroethyl ethers and esters and carbamates are included.

[0065] The type of building block is the type of building block that the building block can Generally, the present invention is limited to those compounds that are compatible with one or more reactive groups capable of forming a covalent bond with the Suitable building blocks include, but are not limited to, peptides, saccharides, glycolipids, lipids. , proteoglycans, glycopeptides, sulfonamides, nucleoproteins, urea, carbamates , vinyl polypeptides, amides, vinylsulfonamide peptides, esters, sugars ides, carbonates, peptidyl phosphonates, azatides, peptoids (oligo N-substituted Glycine), Ether, Ethoxyform Acetal Oligomer, Thioether, Ethylene , ethylene glycol, disulfides, arylene sulfides, nucleotides, morpholin No, imine, pyrrolinone, ethyleneimine, acetate, styrene, acetylene, vinyl , phospholipids, siloxanes, isocyanides, isocyanates and methacrylates. In certain embodiments, (B1) of formula (I) M Or (B2) K are each independently These building blocks are represented by M or K units, respectively, as polypeptides, Polysaccharides, polyglycolipids, polylipids, polyproteoglycans, polyglycopeptides, polysuls Polyamides, polynuclear proteins, polyureas, polycarbamates, polyvinyl polypeptides Polyamides, polyvinylsulfonamides, peptides, polyesters, polysaccharides , polycarbonates, polypeptidyl phosphonates, polyazatides, polypeptoids (O Poly(N-substituted glycine), polyether, polyethoxyformyl acetal oligomer, poly Lithiether, polyethylene, polyethylene glycol, polydisulfide, polyarylate Arylene sulfide, polynucleotide, polymorpholino, polyimine, polypyrrolinone, Polyethyleneimine, polyacetate, polystyrene, polyacetylene, polyvinyl, Phospholipids, polysiloxanes, polyisocyanides, polyisocyanates and polymethacrylates In certain embodiments of the molecule of formula (I), the building blocks are 50 to about 100, for example about 60 to about 95, for example about 70 to about 90%, about 30 to about 500 Daltons, e.g., a molecular weight of about 40 to about 350 Daltons, e.g., about 50 to about 200 Daltons has.

[0066] Building blocks with two reactive groups are used as units. and forming linear oligomeric or polymeric structures, or linear non-polymeric molecules, comprising It is understood that a building block having three or more reactive groups is a building block having three or more reactive groups. It is also understood that it is possible to form molecules with branches at each building block having

[0067] In certain embodiments of the molecule of Formula (I), L1 and L2 are each independently a linker The term "linker molecule" refers to two molecules that can react to form a linker. The term "linker" refers to a molecule that has one or more reactive groups. "Operably" refers to a portion of a molecule that is operably linked or covalently attached to a binding block. The term "linked" refers to the combination of two or more chemical structures that are capable of undergoing multifunctional molecules, including PCR amplification. Attached or co-attached in such a way that they will remain attached through the various operations that are expected to be performed. It means to be bonded.

[0068] In certain embodiments of the molecule of formula (I), L1 is a linker that operably links H1 to D. In certain embodiments of the molecules of formula (I), L2 operably links H2 to E. In certain embodiments, L1 and L2 are linkers that are independently selected from the group consisting of the reaction of L1 and the reaction of L2. One of the reactive functional groups of L1 is reacted with the reactive group of H1, and the other reactive functional group of L1 is reacted with the reactive functional group of D. H1 is bonded to D by reacting with the group, and one of the reactive functional groups of L2 is reacted with the reactive group of H2. and reacting another reactive functional group of L2 with a reactive functional group of E to form the two functional groups that bond H2 to E. In certain embodiments of the molecule of formula (I), L1 and L2 are independently The chemically reactive groups of H1 and D or H2 and E are linked by commercially available linkers. Anchoring molecules, such as PEG (e.g., azido-PEG-NHS, or azido-PEG- amine, or diazido-PEG), or alkanoic acid chain moieties (e.g., 5-azidopentane Acid, (S)-2-(azidomethyl)-1-Boc-pyrrolidine, 4-azidoaniline, or is the N-hydroxysuccinimide ester of 4-azidobutanoic acid; PEG, etc. For example, SM(PEG) n NHS-PEG-maleimide), alkane chains (e.g., 3- (Pyridin-2-yldisulfanyl)-propionic acid-Osu or sulfosuccinimide Diethyl 6-(3'-[2-pyridyldithio]-propionamido)hexanoate) etc. a thiol-reactive linker of formula (I); and an amino-modifying agent (e.g., 6-(trifluoroacetyl) Amino)-hexyl-(2-cyanoethyl)-(N,N-diisopropyl)-phosphoramine dyte), thiol modifiers (e.g., 5-trityl-6-mercaptohexyl-1-[( 2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite, or chemically Co-reactive pair modifiers (e.g., 6-hexyn-1-yl-(2-cyanoethyl)-(N ,N-diisopropyl)-phosphoramidite, 3-dimethoxytrityloxy-2-(3- (3-Propargyloxypropanamido)propanamido)propyl-1-O-succinimide Noyl, long chain alkylamino CPG, or N-hydroxy of 4-azido-butanoic acid Amidites for oligonucleotide synthesis, such as succinimide esters; and their applications It is formed by reacting with a suitable combination such as

[0069] In certain embodiments, the polyfunctional molecule is a molecule of formula (IA) and the molecule of formula (I) It is a subspecies of. (IA) [(B1) M -D-L1] Y -H1-G wherein G, H1, D, B1, M, L1 and Y are as defined above for formula (I). In certain embodiments, the polyfunctional molecule is a molecule of formula (IB), It is a subspecies of. (IB) [(B1) M -D-L1] Y -H1-G-H2 wherein G, H1, H2, D, B1, M, L1, and Y are defined above for formula (I). In certain embodiments, the multifunctional molecule is a molecule of formula (IC), It is a subspecies of the molecule (I). (IC) [(B1) M -D-L1] Y -H1-G-H2-[L2] W wherein G, H1, H2, D, B1, M, L1, L2, W and Y are as defined above for formula (I). In certain embodiments, the multifunctional molecule is a molecule of formula (ID): and are a subgenus of molecules of formula (I). (ID) [(B1) M -D-L1] Y -H1-G-H2-[L2-E] W In the formula, G, H1, H2, D, B1, E, M, L1, L2, W and Y are each independently defined in formula (I). As defined above. In certain embodiments, the polyfunctional molecule is a molecule of formula (IE): and is a subgenus of the molecule of formula (I). (IE)G-H2-[L2-E-(B2) K ] W wherein G, H2, E, B2, K, L2 and W are as defined above for formula (I). In certain embodiments, the polyfunctional molecule is a molecule of formula (IF) and is represented by the formula (I): It is a subspecies of molecule. (IF)H1-G-H2-[L2-E-(B2) K ] W G, H1, H2, E, B2, K, L2, P and W are as defined above for formula (I). In certain embodiments, the polyfunctional molecule is a molecule of formula (IG), ) molecular subspecies. (IG) [L1] Y -H1-G-H2-[L2-E-(B2) K ] W wherein G, H1, H2, E, B2, K, L1, L2, Y and W are as defined above for formula (I). In certain embodiments, the multifunctional molecule is a molecule of formula (IH): and are a subgenus of molecules of formula (I). (IH) [D-L1] Y -H1-G-H2-[L2-E-(B2) K ] W In the formula, G, H1, H2, D, E, B, M, L1, L2, P, Y and W are as defined in formula (I). as defined above.

[0070] The present disclosure relates to a method for synthesizing polyfunctional molecules, such as molecules of formula (I). In the embodiment, at least one terminal coding region on the oligonucleotide, such as G' is [(B1) (M-1) -D-L1] Y -H1 and / or H2-[L2-E-(B2) (K-1) ] W and hybridizing to at least one charge carrier anticodon such as to form a molecule of formula (II). (II) ([(B1) (M-1) -D-L1] Y -H1) O -G-(H2-[L2-E- (B2) (K-1) ] W ) P (In the formula, B1, M, D, L1, Y, H1, O, H2, L2, E, B2, K, W and P are represented by the formula (I) is as defined above, and G' is a sequence including at least two coding regions and at least one It is an oligonucleotide that contains at least one terminal coding region or an oligonucleotide that contains the same. at least two coding regions are single stranded and at least one The terminal coding region is single stranded and is located at the 5' and / or 3' ends of oligonucleotide G'. At least one terminal coding region of each of the sequences differs.

[0071] [(B1) (M-1) -D-L1] Y -H- is (D-L1) Y -Understood to be H1 where M is 1. H2-[L2-E-(B2) (K-1) ] W is H2-(L2 -E) W where K is 1.

[0072] As shown in Figures 1 and 3, in certain embodiments, this method of forming a molecule of formula (II) The advantage of this is that the G' terminal coding region is a first building block and / or a second building block. The nucleic acid sequence of the coding region of a molecule, such as a coding block, may be encoded by a nucleic acid sequence encoding or directing the addition of a coding region for the molecule. For example, each terminal coding region in the molecule of formula (I) may be a first building block D and / or will specifically identify the second building block because the terminal coding region The first building block of the charge carrier anticodon can selectively hybridize to the The identity of building block D and / or second building block E is known. .

[0073] As shown in FIG. 2, in certain embodiments of the method for synthesizing a molecule of formula (I), the method comprises: A series of "select and react" steps are used to generate multifunctional molecules containing different combinations of coding regions. The mixture is immobilized on a hybridization array with one or more coding regions of the multifunctional molecule. Selective hybridization with modified anticoding oligomers results in In certain embodiments of this method, the multifunctional molecules are selected into subpools. Another advantage is that subpools of multifunctional molecules can be combined or mixed for further chemical processing. This separation results in each subpool containing B1 and / or B2 under separate reaction conditions prior to the addition of React with position building block B. In a particular embodiment of this method, the selection and reaction The process can be repeated to add a series of location building blocks. In certain embodiments of the method, a selection and reaction method is used to add building blocks. The advantage is that the identity of each position building block in the encoded portion of the molecule can be determined by the A covalent bond used to selectively separate or classify multifunctional molecules prior to the addition of a blocking block. In certain embodiments, each coding region can be associated with The building blocks are specifically identified according to their position because the The identity of each building block, including the added position building block identity, This is because it can be related to the identity of the reaction process used to add it. In certain embodiments, the method can synthesize multifunctional molecules comprising molecules of formula (I): At least one of the first building block D and the second building block E is At least one of the sequences is identified in or corresponds to at least one of the terminal coding regions and is located at position M. and position building block B2 at position K. At least one of each of the sequences is identified by or corresponds to one of the coding regions. The molecules of formula (I) and (II) are each independently selected from one or more identical molecules between or within the molecules in the pool. It is understood that the molecules in the pool may include upper and lower coding regions. Most, if not all, of the ribosomal DNA have different combinations of coding and terminal coding regions. In a particular embodiment of this method, the coding region and the terminal coding region may be The advantage of a molecular pool having different combinations of It is possible to code multifunctional molecules with coding moieties.

[0074] In certain embodiments of the method of synthesizing a molecule of formula (I), the method includes at least one The method includes providing a charge carrier anticodon, and providing at least one charge carrier anticodon. Chicodon has the formula: ([(B1) (M-1) -D-L1] Y -H1) and / or (H2-[L2-E-(B2 ) (K-1) ] W In the formula, B1, M, D, L1, Y, H1, H2, L2, E, B2, K, and W are each a group represented by formula (I). The term "providing" is generally used to refer to The present invention includes, but is not limited to, the synthesis or commercial purchase of such molecules. The term "codon" refers to a linker between the first building block or the second building block. operably linked to the oligonucleotide G′ or G; An oligonucleotide anticoding region capable of selectively binding to one end coding region In a particular embodiment of this method, a charge carrier atom is introduced into the hairpin structure. The purpose of the chicodon is to ensure that the terminal coding region is a first building block and / or a second building block. The purpose of this method is to code, indicate, or select the addition of a tag. In certain embodiments, the purpose of the charge carrier anticodon is to bind to the first or second building block. The building blocks containing the locks are reacted with oligonucleotides to form molecules of formula (II). and attaching or binding to at least one end of the oligonucleotide G'. The peptide G encodes or synthesizes the positional building blocks B1 and / or B2. This makes it possible.

[0075] In a particular embodiment of the method for synthesizing a molecule of formula (I), an oligonucleotide G′ and a A pool of at least one charged carrier anticodon allows selective hybridization. If the interaction or mixing is possible under conditions that allow the combination step to proceed, ng step) is generally not limited.

[0076] In certain embodiments of the method for synthesizing a molecule of formula (I), at least one oligonucleotide is The step of linking the 5' end of the nucleotide G' to the 3' end of H1 comprises linking the 5' end of G' to the 3' end of H1. The molecule of formula (I) comprises selectively hybridizing the codon region of H1 to the anticodon of H1. In certain embodiments of the method for synthesizing the 3' The step of linking the end to the 5' end of H2 comprises linking the end coding region to the 3' end of G' of H2. This involves selectively hybridizing to the antisense codon.

[0077] In certain embodiments of the method of synthesizing a molecule of formula (I), the method comprises the steps of: linking the 5' end of oligonucleotide G to the 3' end of H1 to form a covalent bond, and / or or linking the 3' end of at least one oligonucleotide G to the 5' end of H2. This ligation step may be carried out during or after the formation of the molecule of formula (II). In certain embodiments of the method, during or after the bonding step, Advantages of forming the covalent bond later include improved processing during other chemical processing steps.

[0078] In certain embodiments of the method of synthesizing a molecule of formula (I), the method comprises: During or after the formation of at least one terminal coding region of a molecule of formula (I) or (II), The method may further comprise the step of removing all of the oligonucleotide from the compound of formula (I). In certain embodiments of the method of synthesizing a molecule, the method comprises: removing all portions of the oligonucleotide from at least one terminal coding region. and wherein at least one terminal coding region is double-stranded and further comprises H1 and and / or H2 hairpin structures, such as the anticodon of the hairpin structure of H1 and / or H2, or can remove oligonucleotides from the G or G' end coding regions. In certain embodiments, at least one terminal code of the molecule of formula (I) or (II) The advantage of removing all or part of the oligonucleotide from the region is that it can be easily removed by chemical treatment during subsequent steps. The improvement of these points is one of the key measures.

[0079] Particular embodiments of the method for forming a molecule of formula (I) as shown diagrammatically in FIG. In this paper, the molecule of formula (I) can be synthesized by multiple synthetic routes by varying the order of process steps. For example, in FIG. 3, two charge carrier anticodons are added in the same step. Then, under the same reaction conditions, building blocks B1 and B2 can be added. In order to add (B 1) M and (B2)K The coding regions of these genes are probably identical if B1=B2 and M=K. do.

[0080] Alternatively, in FIG. 4, one charge carrier anticodon ([(B1) (M-1) - D-L1] Y -H1) is combined and linked with G' to form a molecule of formula (I) where P is zero. Then, to add building block B1, Then, the following selection and reaction steps can be carried out: (B1) M The shape of the coded part Upon completion of synthesis, the second charge carrier anticodon, (H2-[L2-E-(B2) (K -1) ] W ) can be combined and linked with G to form a different molecule of formula (I) where P is 1. Then, the same or different position building blocks and reactions can be Next, carry out the screening and reaction steps to add building block B2 using the conditions In certain embodiments, a pool of molecules of formula (II) and (I) can be selected and Because the types and sequences of reactions used to select and separate the M Reach (B2) K are different. In certain embodiments, (B1) M To form ([(B 1) (M-1) -D-L1] Y Before adding -H1), (B2) K To form a load Charge carrier anticodon (H2-[L2-E-(B2) (K-1) ] W ) at the beginning It is understood that.

[0081] (B1) MOr (B2) K After the complete formation or coding of It is understood that it is not necessary to add an anticodon. Instead, a charged carrier may be added. The subsequent addition of the anticodon is a charge carrier that has been previously added with at least one of B1 or B2. Addition of a second charge carrier anticodon can occur after the addition of a second charge carrier anticodon. Then, building blocks B1 and B2 are added (B1) M Or (B2) K To form In these embodiments, the first code may be selected according to the following steps: At least a portion of the inserted code will match the code added later. , two coded parts (B1) M Or (B2) K is the charge carrier added later. The building blocks differ at least at position 1, which is added before the binding to the amino acid sequence. It will be.

[0082] In certain embodiments, the method of forming a molecule of formula (I) comprises reacting a molecule of formula (II): (II) ([(B1) (M-1) -D-L1] Y -H1) O -G-(H2-[L2-E- (B2) (K-1) ] W ) P with one or more positional building blocks B1 and / or B2 to give a molecule of formula (I) Forming includes: (I) ([(B1) M -D-L1] Y -H1) O -G-(H2-[L2-E-(B2) K ] W ) P In the formula, H1, H2, D, E, B1, M, B2, K, L1, L2, O, P, Y and W are represented by the formula ( As defined for I).

[0083] In certain embodiments, the method comprises the steps of: The step of providing a hybridization array generally includes the steps of: preparing a hybridization array using techniques known to those of skill in the art, without limitation; Alternatively, hybridization arrays can be purchased commercially. In certain embodiments, a hybridization array comprises an array of antibodies immobilized on its surface. The substrate comprises at least two separate regions having a nucleotide codon oligomer. In this embodiment, each region of the hybridization array is bound to a different immobilized anticodon oligonucleotide. The anticodon oligomer includes one or more molecules of formula (I) or (II). The method comprises the steps of: (a) providing a coding region for a nucleic acid sequence comprising: In certain embodiments, the hybridization array uses two or more chambers. In a particular embodiment of this method, the chambers of the hybridization array comprise: This includes particles, such as beads, having anti-codon oligomers immobilized on the surface of the particle. In a particular embodiment of this method, the molecules of formula (I) or (II) are immobilized on an array. The advantage of this step is that it allows the identification of genes based on specific oligonucleotide sequences for each coding region. This means that molecules can be sorted or selectively separated into subpools of molecules. In certain embodiments, the separated subpools of molecules are then subjected to further chemical treatments. , are released separately from the array or removed to a reaction chamber. In the present invention, the release step is optional and generally not limited to, for example, heating, using a denaturing agent, or using a pH of ≧1. This involves dehybridizing the molecule by exposing it to a buffer containing 2. In embodiments, chambers or arrays containing different immobilized oligonucleotides The regions are configured to direct the contents of each chamber or region into an array of wells for further chemical processing. It is positioned so that the solution can flow in.

[0084] In certain embodiments, the method comprises forming a subpool of molecules of formula (I) or (II). To achieve this, at least one building block B, such as B1 and / or B2, is represented by the formula (II), where B1 and / or B2 are of formula (I) In certain embodiments, building blocks B1 and / or B2 are as defined above. Or B2 can be added to the vessel before, during or after the molecule of formula (I) or (II). Reacting building blocks B1 and / or B2 with a molecule of formula (II) or (I) Depending on the coupling chemistry used, the vessel may be subjected to acidic, basic or neutral conditions. It is understood that the reaction may include solvents and co-reactants.

[0085] Methods for identifying probe molecules capable of binding or selecting a target molecule are disclosed. In certain embodiments, the method comprises: detecting a target molecule in which one of the multifunctional molecules is capable of binding to the target molecule; To determine whether a target molecule is a multifunctional molecule, the target molecule is treated with a pool of multifunctional molecules, such as molecules of formula (I). In certain embodiments, the term "exposing" refers to exposing a target molecule to a The present invention includes any method of contacting a probe molecule, such as a molecule of formula (I), Probe molecules that are not bound to the target molecule are separated from the target molecule by using excess solvent. The probe molecules are removed by a removal method such as washing. In certain embodiments, the target molecule In certain embodiments, the target molecule is a protein, an enzyme, a lipid, This includes oligosaccharides and nucleic acids having tertiary structure.

[0086] In a particular embodiment of the method, the amplification step is carried out using PCR techniques known to those skilled in the art: A specific embodiment of the method comprises producing a copy sequence of the oligonucleotide G of formula (I). In an embodiment, the copy sequence comprises at least two coding regions of formula (I) and at least one coding region of formula (I). In certain embodiments, each of the sequences includes at least one copy of the terminal coding region. One advantage of amplifying oligonucleotide G from a target molecule is that the multifunctional molecule is easily isolated from the target. Even if the encoded portion of the multifunctional molecule cannot be easily removed, it still binds to the target molecule. In certain embodiments, the advantages of amplification include the ability to detect a wide range of The aim of this study is to enable the generation of libraries of diverse molecules. The diversity comes at the expense of a small number of molecules of a given formula (I). Amplification by ELISA increases the number of oligonucleotides until they reach a readily detectable number. This allows for the identification of very few copies of the cloned sequences. DNA sequencing and analysis can be performed using multifunctional molecules of formula (I) capable of binding to targets. The encoded portions of the offspring can be identified or correlated.

[0087] Further details on the issue

[0088] The high costs of drug discovery and the associated costs of medicine, research, biotechnology, agriculture, food production, and industry The increasing need to discover molecules with unique and desirable properties for use in It has given birth to the field of binatorial chemistry.

[0089] Finding a molecule with highly desirable properties for a particular desired application is not always straightforward. For example, the binding of the target protein or biological macromolecule or multimolecular structure Molecules that bind to these molecules are extremely difficult to rationally design. When faced with the challenge of discovering molecules that are impossible or inefficient to design, combinatorial Combinatorial chemistry is presented as a viable tool. These can be discovered through the following general process: (a) A researcher creates a Use the best hypothesis about the general properties and structure of the molecule to meet the criteria for (b) researchers can create a set of objects, called libraries, with a hypothetical general nature and structure. (c) designing and synthesizing a large number of molecules having the library members; Any of the bars are tested to determine if they have the characteristics of the desired application.

[0090] When information is limited, hypotheses that can be made about the structure of a desired molecule are limited by those assumptions. It is looser and less clear than when there is a large body of knowledge to provide explanations. When a large amount of data provides a structural hypothesis, the chemical shape assumed to be rich in the desired structure By focusing closely on a region of space, libraries with less complexity or diversity can be created. Lee, e.g. le 4 -1e 7 Unique members are more likely to be successful. If some or none of the features exist, it has more complexity and covers a larger region of the shape space. Libraries that sample and then sample it more deeply, e.g., 1e 5 -le 14 Unique members are required for success.

[0091] Combinatorial chemistry is a method of synthesis using split-and-pool or select-and-react chemical methods. This makes it possible to synthesize libraries of compounds on this scale. Lit-and-pool libraries are synthesized by ligating the DNA strands on a polymeric solid support such as polystyrene beads. It starts with functional groups built into the beads. Thousands to millions of beads are divided into a series of containers, and each container The beads in the vessel are reacted with different chemical subunits or building blocks. Once complete, pool all beads, mix well, and mix with the same or a different set of building blocks. The reaction vessel is then subdivided into a new set of reaction vessels for the second step of the chemical synthesis using a block of The split-and-pool reaction process is repeated until the synthesis is complete. The number of compounds produced by the process depends on the number of beads that can be handled during the process and the number of compounds that can be produced by each step. The only limit is the number of building blocks used in the process. The meter defines the complexity of such a library. For example, every four steps If there are five chemical subunits in 4 =625 members make up the library Similarly, there are 52 building blocks in the first step, 3 in the second step, and 1 in the third step. If there are 384 in the first step and 96 in the fourth step, then 52×5×384×96=3,833.85 Six library members are created.

[0092] The library of molecules is then tested to determine which of them are desirable for the selected application. The amount of molecules produced on a single bead is very large. Identification of such molecules is difficult because they are extremely rare and therefore difficult to identify. The molecular chemistry community is increasingly concerned with the amount of structural data available to guide library design. For properly tuned libraries, larger libraries are highly desirable. It is commonly understood that there is an expectation that a large proportion of people who own a bar will be able to meet their expectations. However, for any given amount of library produced, the greater the complexity, the greater the The more unique molecules in the library, the fewer copies or the more copies of each member. The copy number is low, thus reducing the complexity of the library and the probability of having a successful member. As increases, the total amount of successful members increases, It decreases with the ability to identify.

[0093] Combinatorial chemists face a constrained optimization strategy to ensure that desired members are retained. The goal is to create libraries of sufficient complexity to Generate sufficient copies of each member of the library to ensure that the desired member is accurately identified. Generally, as the complexity of the library increases, the size of the solid support decreases. as the support size decreases, the amount of information available for analysis and identification decreases. The sample volume is also reduced.

[0094] In general, with sufficient resources, it is possible to obtain polystyrene beads in a 1-bead-1 compound library. Top 10 10Synthesize very large combinatorial libraries of unique members However, each polystyrene bead has a volume of 0.1 microliters. If it is, 10 10 The volume of the member library is more than one cubic meter, and the normal Enough to fill a bathtub or bath, perhaps overflowing. Industrial chemical processes often This is done at a scale where processes of this complexity are rarely performed. A library of this size would also be useful for testing such libraries and for those tests. Such a test would require the production of a kilogram of purified protein. Many drug target proteins can require large amounts of protein, and the cost of producing them can be prohibitively expensive. , would be astronomical for many drug target proteins.

[0095] DNA-encoded combinatorial chemical libraries aim to improve this situation. CR can amplify a single template strand of DNA with great precision and the amplified strands can be easily aligned. The fact that the size of the solid support can be determined on a single molecule of DNA allows Therefore, it is possible to reduce the number of very large libraries (e.g., 10 6 -10 14 The ability to generate a population of individual unique members and to identify successful molecules from that population The combinatorial chemical library members are tethered to DNA strands to identify DNA sequences and This can be achieved by establishing a correspondence between the identities of the library members. Then, a selection experiment is carried out. "Selection" refers to the selection of a library population that has a desired trait. This is an experiment in which members of a group are physically separated from non-members. DNA encoding positive library members is amplified by PCR and the DNA sequenced. This method allows the identification of trait-positive library members of a library of enormous complexity. The results are consistent with previous work, in which the authors were able to synthesize trait-positive individuals identified from characteristically small sample sizes. was obtained.

[0096] 10 6 ~10 8 New DNA sequencing technologies that can return individual unique sequences are Facilitates significantly improved analysis of A-coded libraries. The "molecular weight" data allows for robust statistical analysis of highly complex chemical libraries. Species analysis simply identifies the specific individual members of the library that are suitable for a selected application. In addition, we will reveal unknown general traits that confer "fitness" to library members for their intended use. Typically, less well-adapted individuals are selected to become more suitable for the immediate application. DNA libraries prior to selection experiments designed to physically separate combined individuals. Deep sequencing is performed on the post-experiment population, and two data sets are obtained. Comparison of tassets reveals which individuals are more fit because their relative frequency in the population increases. Less fit individuals are identified because their relative frequency in the population decreases. However, DNA-encoded combinatorial chemistry is the most powerful current deep sequencing method. It is possible to create libraries with a complexity far beyond that of conventional sequencing techniques. -Sequencing has demonstrated the usefulness and success of DNA-encoded combinatorial libraries allows for significant advances in, but statistical undersampling of the theoretically available data Only.

[0097] This undersampling data problem is a major issue for all combinatorial chemical processes. This is exacerbated by the fact that processes do not proceed with perfect efficiency. Some reactions go to completion. Loss of fidelity is observed because some reactions do not complete and some reactions form by-products. The DNA sequence returned by deep sequencing identifies the actual molecule it codes for. However, sometimes it can represent a deletion product or a product that is altered by a side reaction. It's not always entirely clear.

[0098] A compounding problem of undersampling is the problem of synthesis fidelity. Not all of the reactions used to create the library are perfectly efficient. This is because Some of the DNA in the code library is not linked to the molecules they code for. rather, it leads to deletion products resulting from incomplete integration of one or more building blocks. This means that the compound is either free of side products or tethered to an analogue resulting from the incorporation of a by-product or side reaction. Thus, some of the genotypes observed to be under survival selection may be related to the genes they encode. Since the data represent molecules other than those being studied, the data analysis has weaknesses.

[0099] directed evolution

[0100] The objective of this disclosure is to maximize current sequencing technology and to reduce undersampling through multigenerational selection. To overcome the ring problem, we have developed a highly complex and high-fidelity DNA-encoded library. Another object of the present disclosure is to identify molecules suitable for a desired application through the synthesis of light. By making it possible to refine the first step of the synthesis of the aryl group, a more accurate synthesis is possible. The key is to make it possible.

[0101] In general, the disclosed method works as follows: A population of molecules is a pool of DNA genes ( The DNA sequence (oligonucleotide G or G') is then The small molecule library members (encoded portions) are synthesized or Translational templates and covalent tethers between DNA genotypes and their corresponding small molecule phenotypes (linker) is established. Genotype-phenotype fusions (library of molecules of formula (I) A population of individuals can be subjected to selective pressure and the DNA (at least 2 The genomic DNA (one coding region and at least two terminal coding regions) was amplified by PCR. The second generation population of (copy sequences) is composed of (a) fit individuals (coding sequences with the desired properties) (b) subjected to deep sequencing and analysis to identify the individual components of the genome; and / or The group is retranslated and a second round of more stringent selection for the same or different properties is performed. The survivors of the second generation of selection are subjected to (a) (b) deep sequenced and analyzed to identify matched individuals; and / or It is translated and subjected to yet another round of selection, sequencing and analysis.

[0102] Generating a library of molecules of formula (I) that can be retranslated and reselected in multiple generations The power of the disclosed methods is a distinct advantage as it allows for directed multi-generational "evolution." Both the initial population of sufficient complexity and the population of survivors after the first round of selection are the best of the best. Undersampled by new affordable deep sequencing methods, and Statistical analysis of sequencing data to identify matched individuals is subject to undersampling Although this is a problem, multiple generation selection allows for a complete analysis of the population. As less fit individuals are eliminated from the population with each successive round of selection, the number of more fit individuals increases. The actual complexity of the population decreases as the number of sequences increases. Increasingly significant sampling is achieved in the band, allowing for very robust computational analysis. The ability to perform multigenerational selection greatly improves this type of analysis.

[0103] The DNA "genes" or oligonucleotides G that comprise the library have a somewhat familiar structure: Like genes in cells, information is arranged along linear sequences. Unlike a typical gene, in this synthetic biology system, a "codon" or coding region is typically It is about 20 bases long. In the natural system, codons start at one end of the gene and In one embodiment of the present disclosure, the gene is read in linear order toward the other end. The coding region includes (a) a sequence beginning with a termination codon, (b) a sequence that is predetermined, and (c) a sequence that is selected from the sequence. They may be read in any order, so long as the prescribed order is maintained in all successive generations of the behavior. In addition, genes also optionally incorporate non-coding regions between each coding region. These non-coding regions can be used to accurately identify the target gene in the library if the non-coding region has a unique restriction site. This facilitates efficient translation and mutagenesis or gene shuffling of the library. The oligonucleotides G in the library typically complete the same number of codons in a similar arrangement. Has full ownership.

[0104] In certain embodiments, for a given library of oligonucleotides G, typically In certain embodiments, there is a predetermined set and number of sequences used in each coding region. In other words, a coding sequence used in one coding region is not used in another coding region. In some embodiments, the coding sequence is a sequence in which all possible combinations of coding sequences are represented. In another embodiment, the genes are assembled in a combinatorial manner, such that The number of combinations of coding sequences was significantly reduced in the initial gene library, and After the event, part of the population undergoes genetic shaping to allow the evolution and selection of new phenotypes. Go through a fling or crossover process.

[0105] In certain embodiments, these "crossover" events place unique restriction sites within non-coding regions. This is facilitated by the partial decomposition of the population in one or more non-coding regions and Subsequent religation results in combinatorial reassembly of the coding sequences between the two coding regions where fragmentation occurred. This shuffling or crossover event allows for the re-assortment of single It may be performed between one pair of coding regions or between multiple pairs of coding regions, or The library is then divided into pools, and each pool represents a crossover event between different combinations of coding regions. In certain embodiments, this ability is achieved by comparing two individuals who have demonstrated fitness through survival selection. The genetic recombination of an individual to code for a different offspring phenotype than either parent This effectively makes it possible. In general, recombination of compatible genotypes produces new, more fit progeny phenotypes for selection. It is born.

[0106] Identifying the coded parts

[0107] In some embodiments, the present disclosure provides a method for the preparation of a nucleic acid sequence comprising the steps of: A molecular probe that has a correspondence between the identity of the molecule that the coding portion or gene encodes. The present invention provides polyfunctional molecules that

[0108] In some embodiments, the correspondence is established as follows: The coding region is prepared so that it is single-stranded and any non-coding regions are double-stranded. do.

[0109] Separately prepare a reactive site adapter. The reactive site adapter (hairpin structure) is as follows: Briefly, in certain embodiments, the reaction site adaptor is typically Specifically, a DNA strand containing a stem region and an anti-coding region is functionalized with a reactive functional group. In certain embodiments, the library has terminal coding regions, so that the same number of different An equal number of reactive site adapters having different anti-coding sequences are provided and prepared. In this embodiment, the reactive site adaptor comprises an amplicon complementary to each of the terminal coding region sequences. In certain embodiments, the reaction site on each reaction site adaptor is prepared using a coding sequence. The reactive functional group site and its sequence are reacted with the first building block to form a charged Reactive site adapters (charged carrier anticodons) are generated and optionally purified to remove unreacted This removes the reactive site adapter of the reaction, providing a significant advantage in translation fidelity. The anti-coding sequence of the reaction site adapter corresponds to a particular building block. The chemistry is described in more detail below. Incubate with the gene library to generate charged reactive site adapters (charge carriers) anticodon) can be specifically annealed to the terminal coding sequence to which it is complementary The annealed adapter / library complexes are then ligated with, for example, T4 DNA ligase. In this way, the terminal coding regions of the gene can be linked together using It corresponds to a building block.

[0110] In certain embodiments, the following selected coding region sequences are combined with the following building blocks: Establishing the correspondence between the coding regions is performed by subpooling the coding regions based on the coding sequences of the selected coding regions. This is accomplished by screening the library. In certain embodiments, the screening comprises: Complementary oligonucleotides immobilized on an array of solid supports called hybridization arrays. This is achieved by sequence-specific hybridization of the single-stranded coding sequence to the oligo.

[0111] The construction of the hybridization array is described below. Briefly, in certain embodiments: In the present invention, a hybridization array is a spatially separated specific hybridization array containing a solid support. In certain embodiments, the substrates are arrays of the code to be selected. There is a covalently attached ssDNA oligo with a sequence complementary to the sequence of the region. In the form, multiple coding sequences are placed on or around a solid support having a given anticode sequence. By irradiating a library of molecules of formula (I) or formula (II) having the following complementary code: The members of the library that have the corresponding nucleotide sequence can be specifically immobilized. In one embodiment, an array of solid supports, each having a different anticode sequence immobilized thereon, is Run the library over the top or bottom and select the library into subpools based on the coding sequence. In certain embodiments, each sequence-specific subpool is then To create a block-compatible sequence, specific building blocks (positional building blocks) This synthesis is described in more detail below and is on the dissociation array, or within a subpool of the array, such as a separate container This can be done after dissolving in a suitable environment and carrying out the reaction.

[0112] of the coding sequence corresponding to the building block relative to all other internal non-terminal coding regions The establishment can be achieved in the same way by using different vectors with different sets of anti-coding sequences. The only difference is that a hybridization array suitable for use in the present invention is used.

[0113] The coding region in the oligonucleotide G can also code for other information. In an embodiment, after translation of the library is completed, a sequence is generated based on the index coding region sequence. In certain embodiments, it may be desirable to sort the library by index. The coding region sequence may be used to select a polypeptide for its intended purpose or for its corresponding subpool of the library. Selection history can be coded, e.g., to parallelize libraries of multiple targets simultaneously. The sequences can be translated and sorted into subpools at the index code region. Subpools for different targets and / or subpools for selection of different conditions The modules are separated from each other and ready for use in their own applications. The selection history of library members that go through multiple rounds of selection is stored in the index area. It can be recorded.

[0114] One intended purpose of the reactive site adapter is to bind the gene live The goal of this study is to establish a correspondence between sequences in a library and specific building blocks. This is accomplished as described above. In general, the key elements of a reactive site adapter are to allow the adapter to hybridize to a specific coding region of oligonucleotide G. the anti-coding sequence, to which the first or second building block D or E can be covalently linked Reactive functional groups, which covalently attach such building blocks to reactive site adaptors A reactive site adaptor or a charged reactive site adaptor comprising a linker and a building block. It is a means for directly or indirectly covalently binding a target to a gene (oligonucleotide G). In some embodiments, the reactive site adaptor comprises a stem, a loop, and itself DNA hairpins containing either a 3' or 5' overhang containing an anticoding sequence In some embodiments, the stem is a fragment that is highly fragmented from the target upon cleavage by a restriction enzyme. or containing one or more unique restriction sites that can facilitate release of tightly bound Pc It contains a good priming sequence that allows for cleaner amplification of the gene by R.

[0115] In certain embodiments, the loop region creates a change in the orientation of the reactive site adaptor strand. Then, the direction of the oligonucleotide G strand is adjusted to match that of the oligonucleotide G strand. Due to the nature of DNA, the coding sequence in oligonucleotide G can be ligated to the end of has the opposite orientation to the anti-coding sequence in the reactive site adaptor. It occurs only between the two ends of a nucleic acid strand that have the same orientation, i.e., 5' to 3'. The strand in the 5' to 3' orientation can be linked to another strand in the 5' to 3' orientation. The orientation of the reaction site adaptor is changed to match the orientation of the oligonucleotide G strand. The oligonucleotide G can be linked to the end of the oligonucleotide G. In an embodiment, the loop of the hairpin structure H1 and / or H2 contains 3 to 12 DNA bases. In some embodiments, the polyethylene glycol glycerin comprises 6 to 12 PEG units. In some embodiments, the reaction site adaptor is an oligonucleotide G. In some embodiments, the terminus of oligonucleotide G is an azide or is functionalized with an alkyne, and the end of the reactive site adaptor is functionalized with an alkyne or an azide. The linkage is achieved by copper-catalyzed "click" chemistry. is suitable for covalently attaching a reactive site adaptor to oligonucleotide G. It will be appreciated by those skilled in the art that

[0116] In some embodiments, the reactive site is located on the PEG linker or the alkyl chain linker. Nucleic acid salts modified by homopolymeric or heteropolymeric chain linkers The reactive site adapter contains a free amine tethered to a group. In some embodiments, the reactive site is functional when In some embodiments, the reactive site is attached 3' to the loop. In some embodiments, the reactive site is located in the same region of the loop as the anticoding sequence. In some embodiments, the anticode sequence is linked to the side of the nucleotide sequence and adjacent to the initial base of the anticode sequence. The reactive site is bound on the opposite side of the loop from the anticoding sequence and distally along the stem. In some embodiments, two or more reactive sites are attached on the adapter. One advantage of having more reactive sites is that it increases the probability of a correctly synthesized coding portion. Another advantage of having more than one reactive site is that the multiplicity of coding portions can be increased during selection. It is possible that affinity will be created and weaker binders will be found in the selection. In some embodiments having reaction sites, the reaction sites are on the same side of the loop and on opposite sides of the stem. In some embodiments, the reactive site is attached near the end of the loop. , and located near the opposite end of the stem. In embodiments, both reactive sites are present in the loop region. The site adaptor includes two or more stems and two or more loops. In this study, multiple reactive sites were attached along the stem, or on the loop, or a combination of both. In some embodiments, the placement and positioning of the reaction sites is determined by the distance between the reaction sites. to promote better avidity based on the size of the target in question. , designed to promote better results in selection.

[0117] In some embodiments, the reaction site adaptor is capable of being easily degraded into smaller fragments. Such fragmentation facilitates better downstream processing of the library. For example, the presence of a linking hairpin at one or both ends of the template library strand can be represented by the formula (I) PCR amplification by interfering with the ability of primers to anneal correctly to the molecule In another example, fragmentation of the charged reactive site adapter after ligation can complicate Reduce steric bulk near the reactive site, improving chemistry or enhancing hybridization The fragmentation method can improve the yield during the synthesis. Restriction digestion at a unique restriction site within the region or the addition of a dU base in the synthesis of a reactive site adapter Incorporation followed by treatment with uracil DNA glycosidase generates an apyrimidine site. The fragmentation procedure includes synthesis of the template strand followed by alkaline hydrolysis of the strand. The reactive site can be left directly or indirectly tethered to or removed from the template strand.

[0118] In some embodiments, the charged reactive site adaptor specifically hybridizes to The first and second end coding regions are linked to the same terminal coding region on both ends of the template strand. When encoding building blocks, these embodiments are In addition, these embodiments have the advantage of providing multiple possibilities for , generating affinity to multiple encoded portions and selecting, especially for weaker binders. It can provide an opportunity to improve efficiency. The first and second building blocks are different. In this case, these embodiments may be used to synthesize unique coding portions for the same number of gene template strands. For some molecules in which the first and second building blocks are of formula (I), If the two building blocks are the same for each molecule of formula (I) and different for the other molecules of formula (I), Allows analysis of the relative contribution of a block to the overall conformance of all code parts do.

[0119] A wide variety of chemistries are available for use in the present invention. In theory, DNA can be chemically Any chemical reaction that does not alter DNA can be used. Reactions that can be used include, but are not limited to, Wittig reaction, Heck reaction, Homer-Wa reaction, ds-worth-Emmons reaction, Henry reaction, Suzuki coupling, Sonogashira cup ring, Huisgen reaction, reductive amination, reductive alkylation, peptide bond reaction, peptide toid bond formation reaction, acylation, SN2 reaction, SNAr reaction, sulfonylation, urea formation, Ourea, carbamoyl, benzimidazole, imidazolidinone, quinazolinone, Dioxins in the formation of isoindolinones, thiazoles, and imidazopyridines, and in the formation of glyoxals cleavage, Diels-Alder reaction, indole-styrene coupling, Michael attachment Addition, alkene-alkyne oxidative coupling, aldol reaction, Fmoc deprotection, triflate These include oroacetamide deprotection, Alloc deprotection, Nvoc deprotection and Boc deprotection. (See Handbook for DNA-Encoded Chemistry.) y (Goodnow RA, Jr., Ed.) pp 319-347, 2014 Wiley, New York. March, Advanced Or ganic chemistry, fourth edition, New Yor k: John Wiley and Sons (1992), Chapters 10 to 16; Carey and Sundberg, Advanced O rganic Chemistry, Part B, Plenum (1990), Chapters 1-1 1; and Coltman et al, Pri ciples and applications of organotransi tion Metal Chemistry, University Science Books, Mill Valley, Calif. (1987), Chap. ters 13 to 20; each of which is incorporated herein by reference in its entirety. (I).

[0120] The multifunctional molecules of the present disclosure include a wide variety of combinatorial scaffolds. It will be understood by those skilled in the art that the scaffolds may incorporate various types of endothelial cells, including the endothelial cells, ... and the endothelial cells. Examples of typical classes include, but are not limited to: (a) End-to-end linked bifunctional building block chains, peptides and peptides tethered are two examples of this type of scaffold; Not all of the building blocks have the same pair of functional groups, and some building blocks It is understood that the aryl group may have only one functional group, e.g., a terminal building block. (b) a bifunctional building block containing several trifunctional building blocks; The branched chain of the lock may or may not contain monofunctional building blocks; (c) Molecules consisting of a single multifunctional building block and monofunctional building blocks In one embodiment, such molecules are a set of multifunctional builders that act as a central core. The building blocks are monofunctional and other monofunctional building blocks are attached as diversity elements. (d) a set of monofunctional or bifunctional building blocks as diversity elements (e) a molecule comprising two or more multifunctional building blocks, to which or building blocks introduced in earlier stages and building blocks on The above-mentioned methods, including the formation of a ring by reacting with a linker introduced in a subsequent step or Any of the scaffolds. Other scaffolds or chemical structure phyla may also be incorporated. These general structural scaffolds provide a set of chemical routes for their synthesis. It is limited only by the ingenuity of practitioners in planning.

[0121] In certain embodiments, ion exchange chromatography binds to DNA in two ways. Facilitates chemical reactions carried out on flowing substrates. For reactions carried out in aqueous media, DEAE-SEPHAROSE® or TOYOPEARL® Sup Easily purify by pouring the reaction onto an ion exchange resin such as erQ 650M In certain embodiments, the DNA is bound to the resin by ion exchange. Unused reactants, by-products and other reaction components can be dissolved in aqueous buffer, organic solvent or a mixture of both. There are real problems with reactions that work best in organic solvents. However, DNA is very poorly soluble in organic solvents, and such reactions have low yields. In this case, the library DNA is immobilized on an ion exchange resin and the residual water is removed with a water-miscible organic solvent. The reaction may be carried out in an organic solvent, which may or may not be water-miscible. RM Franzini, et.al. Bioconjugate Chem See Istry 2014 25(8), 1453-1461 and references therein. Many different chemical properties or properties that make them more or less suitable for different applications. There are several types and varieties of ion exchange media, including THERMOFISHER® ), SIGMA ALDRICH(R), DOW(R), DIAION(R) Only a few are named, such as TOYOPEARL (registered trademark) and TOYOPEARL (registered trademark). They are commercially available from a number of companies. For the purpose of performing chemical reactions to remove or activate moieties for further modification. There are many other methods not described herein that can fix or solubilize the library DNA. It will be appreciated that there are many possible means and mediums for

[0122] In certain embodiments, the hybridization array contains a heterogeneous mixture of ssDNA sequences. and a device for selecting, the selecting being a complementary sequence fixed in a position addressable format. By sequence-specific hybridization of these sequences to oligos. See, e.g., U.S. Pat. See US Pat. No. 5,759,779. Hybridization arrays are widely used in It is understood that the physical form of the hybridization agent may be any suitable form. The application arrays are constructed by mixing heterogeneous substrates that come into contact with complementary oligos immobilized on the surface of the array. and capable of reacting with a sample or ssDNA (i.e., a library of compounds of formula (I)). The complementary oligos are then hybridized to the immobilized oligos of ssDNA in a sequence-specific manner. Immobilized on the surface of the array to enable, permit, or facilitate the In certain embodiments, ssDNA immobilized via a common sequence is also immobilized. sDNA can be independently removed from the array to form subpools.

[0123] In some embodiments, the hybridization array has a thickness of 0.1 to 100 mm. It contains a rectangular sheet of plastic sized with a series of holes, called "features," cut into it. In a particular embodiment, the filtration membrane is attached to the lower and upper surfaces of the sheet. In certain embodiments, the "solid support" is a feature enclosed between the filtration membranes. In certain embodiments, any given surface or collection of solid surfaces may be In this technique, a single sequence of oligos is immobilized on a solid support.

[0124] In certain embodiments, the library of molecules of formula (I or II) comprises: Selection is performed on the array by causing an aqueous solution to flow over and through the features. In certain embodiments, members of the library can be differentiated by their complementary sequences. When it comes into contact with an oligo in a feature that it is attached to, it becomes immobilized within the feature. In certain embodiments, after hybridization is complete, the features of the array are Can be placed on a receiving vessel such as a 6-well plate or a 384-well plate In certain embodiments, an alkaline solution that causes dehybridization of DNA can be added to each feature, and the solution will accumulate the now mobilized library. Transfer to a receiving vessel. Other dehybridization procedures, such as the use of hot buffers or denaturing agents, may be used. Thus, in certain embodiments, a library of molecules can be generated using sequence-specific The method can be used to sort the subpools.

[0125] The chassis described above may be constructed of plastic, ceramic, glass, polymer, or metal. It will be understood that the solid support may be made of any suitable material, including resin, glass, metal, plastic, polymer, etc. It is understood that the support may be made of a material selected from the group consisting of a ceramic, a porous material, and a non-porous material. A higher surface area on the solid support allows for greater amounts of complementary oligos to be immobilized. This allows for a larger amount of library subpools to be incorporated into the feature. The solid support may be any suitable material, including nylon, plastic, fabric, polymer, glass, ceramic, etc. or that they can be retained in their respective features by a filtering membrane made of metal. It is understood that the solid support may be a glue, adhesive, or a chassis and / or other Their respective filtration membranes may be fused to the support by means other than a filtration membrane, such as covalent attachment of the support to the support. It will be understood that the feature may be a hole in the chassis. It does not have to be a hole, but it should have a separate part that can be removed from or placed on the chassis. It is understood that the chassis is a structure that is vertically arranged. It does not have to be a rectangle with a square, but it can have features arranged in one or three dimensions. It will be understood that the shape of the prism may be a cylinder or a rectangular prism. See US Pat. No. 9,779.

[0126] A library of molecules of formula (I) can be considered as a population of phenotypes constrained by their respective genotypes. Such populations are subject to selective pressures that remove less fit individuals from the population. The second generation of the population is exposed to forces, allowing the fittest members to survive. The G genotypes - those that survived - were amplified by PCR and reconstituted. Either the clones are translated and subjected to another, more stringent selection for the same trait, or several The selected surviving subpopulations are typically selected for orthogonal traits. The sequence can be determined using either genomic sequencing or next-generation sequencing techniques. , analyzing the sequencing data to identify the best-matched coding portion (phenotype) can be done.

[0127] Many types of selection can be performed. The most typical selection is to select for targets that bind to the target protein. In certain embodiments, such a method is performed to find individuals in a population who can A suitable method for selection is to label wells in a NUNC MAXISORP® plate. The target protein is immobilized on a solid support such as a surface, or the target is biotinylated and stained. By immobilization on streptavidin-coated magnetic beads. In certain embodiments, the target After immobilization of the target, the population of molecules of formula (I) is incubated with the target on the support. All those individuals capable of binding do so and become immobilized themselves. The solid support is washed with an appropriate buffer to remove non-binders. The DNA encoding the inhibitor was amplified by PCR and used for sequencing prior to retranslation. and are subjected to another selection round.

[0128] In certain embodiments, selection involves separating individuals that bind to one target protein from individuals that bind to a different, anti-target protein. The method can be carried out by selectively excluding a target, a protein, or a set of anti-target proteins. In such cases, one method of choice is to place both the target and anti-target on a solid support in separate vessels. In certain embodiments, the library is first constructed by immobilizing the anti-target The individual that is able to bind to the anti-target will do so. In an embodiment, the non-binders are carefully removed from the container and transferred to a container containing the target. In this way, a population selected for the ability to bind to a target can bind to an anti-target. The selection is based on the ability to bind to the target or the elimination of anti-targets. Produces individuals with characterized fitness.

[0129] In certain embodiments, coding segments that selectively bind one target to another are identified. The second method involves performing similar selection for both targets and then during analysis of the sequencing data. The coding portions that show affinity for both targets are eliminated.

[0130] In certain embodiments, by using a mixture of immobilized and free targets, Selection can also be made to select binders with long off-rates. In certain embodiments, the library is incubated with an immobilized target. An excess of free target is then added and allowed to bind. During this time, the antibodies that are released from the immobilized target and then rebind are incubated for 1 h. The non-binders are likely to rebind to the free target. The target and its bound counterparts are washed away. The only binders left on the free target are , binders whose off-rate is longer than a given incubation time of the free target.

[0131] The selection methods described in the previous paragraph include phage display, ribosome dissociation, and These methods can be found in the literature on spray and mRNA display. Stutz, Patrick, et al., Cell biology: a labo ratory handbook, 3rd ed.ELSEVIER, Amsterdam m(2006):497-509 and references therein.

[0132] In principle, the objective is to selectively amplify individuals in a population that have a trait relative to individuals that do not have the trait. , selection can be made about any characteristic, provided that means can be constructed. Pharmacological selection involving properties other than target binding is in principle possible; examples include hydrophobicity, These include, but are not limited to, selection based on solubility, cell membrane permeability, and non-toxicity.

[0133] By synthesizing a sufficient amount of the library, multiple selections can be performed in a given round. It will also be appreciated that in certain embodiments, subpopulations of survivors following selection for affinity to a target may be used. The populations are isolated, optionally purified, and analyzed for affinity to the same or different targets. The clones are subjected to a second selection or selected for orthogonality. The subpools are then amplified by PCR and sequenced or subjected to further selection. The gene is amplified and retranslated for selection.

[0134] In certain embodiments, the sequencing data is used to identify library members in the population before and after selection. In certain embodiments, the bar display is compared to the bar display. The unselected members are typically considered less fit and tend to be more likely to be selected after selection. Members that are more frequently represented are considered to be a better fit. Furthermore, data are Which individual building blocks provide compatibility when combined with the building blocks? Which pairs of building blocks confer compatibility, which triplets of building blocks In certain embodiments, the data is analyzed to determine whether the data provide a match. , which structural elements are in different building blocks and in different code parts? confers fitness to selected members of the library. In this study, these analyses provide information on which members should be combined for independent testing. and similar to be created and tested that may not be original members of the library. In certain embodiments, the three-dimensional docking algorithm is It can also provide information to the process.

[0135] In certain embodiments, the library members identified in the data analysis are typically The method comprises the steps of: It can be synthesized with or without an oligonucleotide portion. These independently synthesized samples were then subjected to various tests to characterize their physical and chemical properties. The compounds are subjected to experimental testing to indicate their general suitability for the desired task. These properties include, but are not limited to, the affinity of the library member to its target. The dissociation constant, or KD, which measures how tightly a molecule binds to another molecule, is measured by water:octanol fractionation. and its water solubility as measured in CaCo cells.

[0136] In certain embodiments, library members identified that bind to a biomolecule are used to: The biological function of the biomolecule can be confirmed. The functions of the proteins are unknown and the methods of the disclosure provide molecules that can aid in elucidating their function. In certain embodiments, the methods of the present disclosure provide a rapid route to probe discovery. The identified library members are intended to be useful for targeting biomolecules for small molecule discovery and drug therapy. These can be used to help determine whether a particular antibody is specifically suited for a given drug.

[0137] In certain embodiments, the library member is linked to a biomolecule function to which it is attached. Effects can be assessed using in vitro or in vivo assays, cell-based assays or non-cell-based assays. For biomolecules with known functions, their The effect of the identified library members on function can be evaluated. If is an enzyme, the effect on its rate of activity can be evaluated. In the case of a transduction protein, it is possible to induce cell viability, cell gene expression, or cell phenotype expression. If the target is a viral protein, the effect on viral function can be evaluated. The effect of library members on proliferation and viability can be assessed.

[0138] In certain embodiments, library members identified through selection are subjected to in vivo experiments and to evaluate their effects on animal, human and plant health. can.

[0139] In certain embodiments, the library members identified through selection also comprise biomolecules. It can be used as an affinity reagent for the purification of a target. The encoded portion can be immobilized on a solid support and a heterogeneous solution containing the target can be contacted with the solid support. In certain embodiments, the target is bound to a coding portion and can be immobilized. In certain embodiments, all other components of the mixture are washed away to provide a purified sample of the target. can be left behind.

[0140] The present invention is illustrated by the following examples, but is not limited thereto. Any person skilled in the art will recognize many equivalent techniques for accomplishing the steps or portions of the steps recited herein. will recognize. EXAMPLES

[0141] An embodiment of a molecule of formula (I) is constructed as follows:

[0142] Example 1: 8 x 10 9 Construction of member gene library

[0143] Provision of codons for gene libraries. 96 double-stranded DNA ("dsDNA") sequences are Genscript, Piscataway, NJ; Monmouth, NJ Synbio Technologies of Junction, Wilmington, Delaware Biomatik, Epoch Life Sciences, Sugar Land, Texas These sequences are provided or purchased from gene synthesis companies such as NCEs. Each coding region contains 5 coding bases, each of which contains a 20-base noncoding region (for a total of 6 noncoding regions). All coding region sequences are unique and are flanked on either side by The DNA molecule is selected so as not to cross-react with other coding and non-coding regions. Although the two noncoding regions have different sequences, the sequence at each position is conserved across all DNA All coding and non-coding regions have similar melting temperatures (58°C to 62°C). The coding and non-coding regions are designed in silico as follows: The DNA sequences are randomly generated in silico.

[0144] Once generated, the melting temperatures and thermodynamic properties (melting delta H, delta S) of the sequences are determined. and delta G) are calculated using the nearest neighbor method. The calculated Tm and other thermodynamic properties are If the sequence does not fall within the predetermined range desired for the library, it is rejected. The sequences are subjected to analysis by sequence similarity algorithms. Sequences predicted by the algorithm are assumed to be non-cross-reactive and are retained; others are rejected. The coding and non-coding regions are identified using oligonucleotides that have been shown to be non-cross-hybridizing. Giaever G, Chu A, Ni L,Connelly C,Riles L,et al.(2002)Functio nal profiling of the Saccharomyces cerev isiae genome. Nature 418:387-391. The literature lists 10,000 non-cross-reactive oligos. The Tm of each is calculated, Those that fall within a given range are analyzed by a sequence homology algorithm. Things are kept.

[0145] Each non-coding region contains a unique restriction site. The non-coding region at the 5' end of the template strand is The SacI recognition site is located at bases 13-18 from the end of the coding strand. contains an EcoRI restriction site at bases 14-19 from the 3' end of the template strand. The second, third, fourth, and fifth noncoding regions from the end contain the Hind It has recognition sites for III, NcoI, NsiI and SphI.

[0146] The DNA is restriction digested to delink all codons from each other. The DNA sequences are pooled and approximately 20 μg / ml from New England Biolabs (NEB, Massachusetts). The cells are dissolved in CUTSMART® buffer provided by NEB. Internal restriction enzymes HINDIII-HF (registered trademark), NCOI-HF (registered trademark), and NS II-HF® and SPHI-HF® were added and the enzymes were incubated according to the manufacturer's protocol. Digest the DNA at 37°C for 1 hour according to the protocol. Heat inactivate the enzyme at 80°C for 20 minutes. After inactivation, the reaction was held at 60°C for 30 minutes, then cooled to 45°C and held for 30 minutes. and then cooled to 16°C.

[0147] Codons are combinatorially reassembled to create a gene library. The individual codons were reassembled into full-length genes using T4 DNA ligase from NEB. The enzyme was added to 50 U / ml, and dithiothreitol (DTT, Thermo Fish (Ed. Scientific, Massachusetts) was added to 10 mM, and adenosine Add ATP (NEB) to 1 mM according to the manufacturer's protocol. The ligation reaction is carried out for 2 hours and the product is purified by agarose gel electrophoresis. The sticky ends generated by digestion at one site of the provided gene are then used to cleave all other sites at the same site. The nucleotides anneal to the sticky ends of all digestion products, resulting in complete combinatorial reassembly. Therefore, if the 96 provided genes each consist of 5 codons, then there are 965 genes are generated. Since there are 96 coding sequences at each of the 5 coding positions, 96 5 =8×10 9 There are combinations or library members of

[0148] A gene library is prepared for translation.

[0149] Amplify the gene library by PCR. The T7 promoter is To add a 5′ end to the non-template strand by extension PCR use these reactants: 5x PHUSION® High-Fidelity DNA Polymerase (" PHUSION® Polymerase (NEB), 10 μL; dNTP solution mixture, 200 μM final concentration; forward primer, 750 final concentration nM; reverse primer final concentration, 750 nM; template (to properly overlay the library) Sufficient template must be used to sample; dimethyl sulfoxide (D MSO), 2.5uL; "PHUSION® Polymerase", 2μl. 57°C Perform PCR using an annealing temperature of 100°C and an extension temperature of 72°C. Wait 5 seconds for each cycle. anneal; extend for 5 seconds each cycle. Products were analyzed by agarose gel electrophoresis. do.

[0150] Transcribe DNA to RNA. Without purifying the PCR product, a 250 μL transcription reaction was performed as follows: Reactions performed with: PCR product, 25 μL; RNAse-free water, 90 μL; Nu nucleotide triphosphates (NTPs), 6 mM final concentration each; 5x T7 buffer, 50 μL; NEB 250 units of T7 RNA polymerase; optionally, RNasin® ribonuclease Add enzyme inhibitors (Promega Corporation, WI) to a concentration of 200 U / ml. Optionally, pyrophosphatase can be added up to 10 μg / ml. 5x T7 buffer is 1M HEPES-KOH (4-(2-hydroxyethyl)-1 -piperazineethanesulfonic acid) pH 7.5; 150 mM magnesium acetate; 10 mM 200 mM spermidine; 200 mM DTT. The reaction is carried out at 37°C for 4 hours. Purify the RNA by ethanol precipitation. Dilute the transcription reaction with 1 volume of water. Add LiCl to 3M Spin at maximum g for at least 1 hour at 4°C. Decant and store the supernatant. A clean pellet is a clear glassy gel that is difficult to dissolve. Alternate between incubation at 4 °C for 1 min and gentle vortexing to resuspend the pellet. Analyze by agarose gel electrophoresis, quantitate and freeze as soon as possible to avoid degradation. For example, Analytical Biochemistry 195, p207-213 (1991), and Analytical Biochemistry 220, p42 Please refer to 0-423, (1994).

[0151] RNA is reverse transcribed into DNA. Single-stranded RNA ("ssRNA") is reverse transcribed into DNA using Thermo F SUPERSCRIPT® III Reverse from Isher Scientific Reverse transcription in a two-step procedure using the transcriptase and the supplied First Strand Buffer. The first step is carried out with these final concentrations of the following components: dNTPs , 660 μM each; RNA template, ~5 μM; primers, 5.25 μM. Step 1 Heat the ingredients in step 2 at 65°C for 5 minutes and then chill on ice for at least 2 minutes. The final concentrations were: First Strand Buffer, 1x; DTT, 5mM; RNase A, 1x; ase inhibitor (NEB), 0.01 U / μL, SUPERSCRIPT® II I reverse transcriptase, 0.2 U / μl. Mix the ingredients of step 2, warm to 37°C, and add to step 1. After cooling the ingredients on ice for 2 minutes, add the mixture from step 2 to the mixture from step 1. The resulting portion is reacted at 37°C for 12 hours. After the reaction, agarose gel electrophoresis is performed. Starting material RNA and a known product or a set of known products such as a PCR product library Samples of the analogue reactions were taken. All samples were diluted with ethylenediaminetetraacetic acid (EDTA ), heat to 65°C for 2 minutes, quick cool, and then run on an agarose gel. RNA should degrade from the complementary DNA ("cDNA") product. isopropanol and ammonium acetate were added to 2.5M, followed by 100 ml of 48,000 g of Purify the cDNA product by centrifugation for 1 h. Wash the cDNA pellet with distilled water (" Resuspend in dH2O (pH 7.5) and dehydrate the RNA strands by adding LiOH to a pH of 13. Heat the solution at 95°C for 10 minutes. 5 equivalents were added, and the pH was adjusted to 100 with tris(hydroxymethyl)aminomethane ("Tris") and The reaction was neutralized with acetic acid and the mixture was slowly cooled to room temperature and immediately concentrated to remove the buffer. Exchanged into NEB CUTSMART® buffer.

[0152] Removal of terminal non-coding regions. Reverse transcription with complementary oligos to create a double stranded non-coding region. The ssDNA product was diluted in NEB CUTSMART® buffer at 100 μg / ml. The restriction enzymes SACI-HF (registered trademark) and ECORI-HF (registered trademark) manufactured by NEB are used. Add 100 mM NaCl to a concentration of 1 U / μg of DNA. Incubate the digest for 1 hour at 37°C. The mixture is incubated at 65° C. for 20 minutes and the enzyme is then heat inactivated at 65° C.

[0153] The reactive site adaptor is prepared for translation.

[0154] Providing reactive site adapters. Two sets of 96 reactive site adapters are provided, each of which has a helix of 1000 bp. It contains an overhang containing an amplified loop, a stem, and an anti-coding sequence. The 3'-terminal coding region of the template strand is specific for the 3'-terminal coding region, which appears after removal of the 3'-terminal non-coding region. the other set has a 3' overhang anti-coding sequence that hybridizes to 5 It appears after removal of the 5'-terminal non-coding region, but hybridizes specifically to the 5'-terminal coding region of the template strand. It has a 5' overhanging anti-coding sequence that ligates the 3' overhanging In this example, the stem regions of each set are provided with a 5' phosphoryl group. have the same sequence of the corresponding terminal non-coding regions that were previously removed by restriction digestion. The loop region of each set contains a linker reaction site, N4-TriG1-amino 2' deoxyribonucleic acid. The bases are modified with cysteine ​​(IBA, Goettingen, Germany). The adapters described were purchased from Sigma Aldrich, Coralville, IA, USA. integrated DNA Technologies, Louisville, Kentucky They can be purchased from DNA oligo synthesis companies such as Eurofins MWG.

[0155] Charge the reaction site adapters. Place two sets of six reaction site adapters in separate wells. Add 15 μl of TOYOPEA and dissolve in TE buffer (Promega, MA). RL® SuperQ-650M (Sigma-Aldrich, St. Louis, MO) Place 100 μl of 100 μl of ion exchange resin into each well of the filter plate. 3. Wash with 2 mM HOAc. Add an aliquot of each reactive site adapter proportional to the amount of template strand. Transfer them to separate wells of a filter plate and immobilize them on the resin. The cleaved adapter was purified with dHO, then piperidine, then dimethylformamide (DM F). 96 separate reaction solutions were prepared, each containing 50 μl of DMF, Fmo c Protected amino acid 75 mM, 4-(4,6-dimethoxy-1,3,5-triazine-2-yl N-methylmorpholinium tetrafluoroborate 75mM, 90mM These mixtures were allowed to react with the acid for 10 minutes at room temperature, then the resin was The resin was then washed with 4×100 μl DMF and freshly The coupling step was repeated with the prepared reaction mixture, washed again with DMF, and diluted with 20 50 μl of 50% piperidine was added to each well to remove the Fmoc protecting group and incubated at room temperature for 2 h. The resin is rehydrated 4x with 100 μl DMF, then 3x with 100 μl dH2O. The charged site adapter is prepared in 1.5M NaCl, 50mM KOH, 0.01 The resin is eluted with 100% Triton® X-100. The solution is neutralized by adding HOAc to pH 7.4 and 15 mM. The electrochemical reaction site adapters were pooled and packed in ZEBA® 7K MWCO (Thermo by passing it through a desalting cartridge (Fisher Scientific, MA). Desalt it.

[0156] Library Translation

[0157] Ligation of charged reactive site adaptors to the library. Braly is using ZEBA® 30K MWCO (Thermo Fisher Scientific scientific, MA) 50mM Tris-HCl, 10mM Mg in a centrifugal concentrator. Buffer exchange with Cl2, 25 mM NaCl at pH 7.5, 25°C. Template strand Add 1.1 equivalents of a specific charged reactive site adaptor to the 3' end of the template strand; Add 1.1 equivalents of end-specific charged reactive site adaptor and dilute the mixture to 1 μM in the same buffer. The reaction is heated at 65°C for 10 min and cooled to 45°C over 1 h. After cooling to room temperature, DTT was added to 10 mM, and ATP was added to 10 mM. Add 1 mM ribosomal buffer and T4 DNA ligase to 50 U / mL. The reaction was carried out at room temperature for 12 hours, then the enzyme was heat inactivated at 65°C for 10 minutes, and the reaction was allowed to proceed slowly. The reaction was then buffer exchanged into 150 mM NaCl, 20 mM citrate, 15 mM Tris, 0.02% sodium dodecyl sulfate ("SDS"), 0. 0.5% Tween 20 (Sigma-Aldrich), pH 7.5, 30K molecular fraction Concentrate using a MWCO centrifugal concentrator.

[0158] Preparation of hybridization arrays. Hybridization arrays are 2 mm thick. TECAFORM® (Acetal Copolymer) chassis The holes are cut using a computer numerical control. ING nylon 40 micron mesh is attached using Nitto Denko NP200 double-sided tape. The CM Sepharose is then functionalized with an azide group. The holes are filled with a solid support of .DELTA.M. resin (Sigma Aldrich). , 8 PEG monoclonal antibodies purchased from Broadpharm (San Diego, CA). The loaded CM Sepharose is functionalized with azido-PEG-amine bearing 45 ml of DMF is placed in a fritted funnel and washed with DMF. The resin is then added to 90 ml of Suspend in 1 ml of DMF, 4.5 mM azide-PEG-amine, 75 mM EDC, 7. The resin was reacted with 5 mM HOAt at room temperature for 12 hours. The tissue is then washed with ethanol 20% at 4°C. The azide group is used to attach the alkyne-linked oligo to the top of the chassis. The array can be attached to a solid support using an array / well plate adapter. azido-SEPHAR by placing the adapter on the well plate and Capture oligos on the OSE® and "click" them into the register 1 nmol of alkynyl oligo, copper sulfate, 625 μM tris(3-hydroxybutyric acid) (Trioxypropyltriazolylmethyl)amine ("THPTA") (ligand), 3.1 mM Aminoguanidine, 12.5 mM ascorbate, 12.5 mM phosphate buffer Add a solution containing 100 mM H7 to each well of the array / well plate adapter. After 10 minutes, the solution is centrifuged. Rotate the plate from the array at 100° C. and then immediately rotate the reaction on the array for a second pass. After the second 10-minute reaction, the reaction solution is dispensed into the well plate. Rotate the well plate inwards and set aside. Wash the array thoroughly with 1 mM EDTA and 0.5 mM EDTA. The reaction solution is stored in phosphate buffered saline ("PBS") containing 0.05% sodium azide. Each was diluted to 100 μL with dHO and subjected to diethylaminoethyl (DEAE) ion exchange. Load onto resin and wash with dH2O to remove all reagents and oligos except for unincorporated oligos. The solutions were analyzed by high performance liquid chromatography (HPLC). The array is analyzed to determine the extent of incorporation due to disappearance of the starting material. Each coding position has a separate oligo. arrays are created.

[0159] Selection of libraries by sequence-specific hybridization. The library for the PCR reaction was then hybridized in 1x hybridization buffer (2x sodium citrate). Sodium chloride (SSC), + 15 mM Tris pH 7.4 + 0.005% TRITON (registered Dilute to 13 ml with 100% PBS (0.02% SDS, 0.05% sodium azide). Add 10 μg of transfer RNA ("tRNA") to detect nonspecific nucleic acid binding. Block the sites. The array is selected to correspond to the desired coding positions in the template library. The array is placed in a chamber that provides a gap of 1-2 mm on either side and is then Inject 3 ml of library solution. Seal the chamber and incubate gently at 37°C for 48 hours. Optionally, pre-pattern the plates as a means of faster sorting of the libraries on the array. The solution containing the library is directed through various features in a coded pathway. The array is placed in an apparatus that allows for

[0160] The selected library is eluted from the hybridization array. Open the chamber and replace the hybridization solution with fresh 1x Hybridization Buffer. The plate is washed by exchanging the buffer with water and shaking for 30 minutes at 37°C. Repeat three times with hybridization buffer, then twice with 1 / 4x hybridization buffer. The library is then eluted from the array. The array is then returned to the array / well plate. Place in the adapter and add 10 mM NaOH, 0.005% TRITON® X-1 Add 30 μl of 0.1 mL of 100% PBS to each well and incubate for 2 minutes. The elution procedure is repeated three times. 9 μl of 1M Tris pH 7.4 and 9 μl of 1M HOAc were added to each well in that order. Neutralize by adding to a well.

[0161] A peptoid coupling chemistry step is carried out on the sorted library. Add a 15 μl aliquot of SuperQ 650M resin to each well of the filter plate. The selected library is then washed with 100 μl of 10 mM HOAc. Spin during elution of hybridization array into well plate with exchange resin The resin and library are transferred from the well plate to the register in 1 x 90 μl of 1 0 mM HOAc, 2 x 90 μl dH2O, 2 x 90 μl DMF, 1 x 90 μl pipet Wash with 1x 90 μl of peridine. Separately, wash with 100 mM sodium chloroacetate and 150 mM 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmono A solution of sulfolinium chloride in methanol is prepared. 40 μl of this solution is added to the resin. Add 100 µl of each well and incubate at room temperature for 30 minutes. Wash the resin with 3 x 90 µl of methanol. Repeat the coupling and wash with 3 x 90 μl methanol and 3 x 90 μl DMSO. Separately, a solution of 2M (or saturated, if necessary) of the primary amine in DMSO is Add 40 μl of one of the primary amine solutions to each well of resin and incubate at 37° C. for 12 h. The resin was diluted with 3×90 μl of DMSO, 3×90 μl of 10 mM acetic acid (HOA c) Wash with 3 x 90 μl dH2O. 1.5 M NaCl, 50 mM NaOH, DNA labeling was performed using 0.005% TRITON® X-100. The library is eluted in 3 x 30 μl portions. All reactions are pooled and diluted with Tris for 15 min. The solution is neutralized by adding 1x HA to 1 mM and HOAc to pH 7.4. Concentrate and buffer exchange into hybridization buffer.

[0162] Complete the synthesis of the library. Hybridization assay using the protocol above. The above protocols for screening libraries and performing peptide or peptoid chemistry on a screen are described below. 3. Use the protocols of Examples 10-32 below to carry out the synthesis, synthesis, or other chemical steps. Three further selection and synthesis steps are performed to fully translate the library.

[0163] Prepare the library for selection. Once library translation is complete, dilute the library in 1.0 µM The following: dH2O, 1x DREAMETAQ® buffer, 10000x d NTP [template], 0.2 U / μL DREAMTAQ® polymerase, and The libraries were combined as templates in a mixture supplemented with an equal amount of MgCl2 relative to dNTPs. The single-stranded region can be optionally double-stranded by combining the 3'-reactive site adapter. Note that the chromatin acts as a primer for the chromatin. The mixture was heated at 95°C for 2 min. The DNA was then annealed at 57°C for 10 seconds and extended at 72°C for 10 minutes. The reaction mixture is purified.

[0164] Select a ligand that binds to the protein target of interest. 5 μg in 100 μl PBS 100 ml of streptavidin per well of a MAXISORP® plate at 4°C. Shake overnight to fix. Wash wells with 4x340ul of PBST. One was blocked with 200 μl of casein, and the other two were blocked with 5 mg / ml of BSA at room temperature for 2 hours. Wash wells with 4 x 340 μl PBST. Add 5 μg of bisphosphonate in 100 μl PBS. The tinned target protein was added to wells blocked with casein and wells blocked with BSA. Add 100 mL of 1000 mM NaCl and incubate at room temperature with shaking for 1 hour (probe for biotinylation of proteins). For tocophores, see Elia, G. 2010. Protein Biotinylation on,Current Protocols in Protein Science, 60:3.6:See 3.6.1-3.6.21). Contains Tween 20 (PBST) Add 100 μl aliquots of the translated libraries in PBS containing the target protein. Add 100 μl PBST to each well containing no target protein. Add 100 µL of 10 ... The fluid was carefully aspirated from the wells containing only the immobilized target protein and PBST. The buffer containing the library in the target-free wells is carefully transferred to the target-containing wells. Add 100 μl of PBST to wells that do not contain targets. Shake all at room temperature. Incubate for 4 hours with shaking. Carefully pipette out the library and save it. Wash wells 4x with 340 μl PBST. To elute the library members, add excess biotin in 100 μl of PBST to the well. Add the mixture to the PCR reaction tube and incubate at 37°C for 1 hour. Carefully aspirate off the buffer and discard the PCR reaction. It is used as a template.

[0165] Analyze the selection results. PCR products from the libraries before and after selection are analyzed by DNA sequencing. Deep sequencing using primers and protocols required by the service provider The vendors are Seqmatic, of Fremont, California; Elim BioPharm, Hayward, Pennsylvania. The coding sequence of the internal coding region is analyzed to identify the building blocks that will be used to synthesize the coding portion. The relative frequencies of identified library members before and after selection estimate the library lock. This indicates the degree to which library members have been enriched in a population by selection. Analysis of various chemical subgroups, including member survival selection, has demonstrated that these moieties are - To show the degree of fitness of members and to evolve more fit molecules or to It is used to predict similar molecules for further synthesis and analysis.

[0166] Example 2: Preparing and translating libraries with single reactive site adaptors.

[0167] Libraries with a single reactive site adaptor are constructed by: (a) inserting the adaptor into one of the terminal non-coding regions; and (b) the steps of ligation of the corresponding reactive site adapter are omitted. Prepared exactly as in Example 1, except:

[0168] Example 2a: A library was prepared with a single reactive site adaptor at the 5' end of G. , and translate. A library with a single reactive site adapter at the 5' end of the coding strand of G To prepare the library, the library was prepared according to the procedure described in Example 1, except for the "removal of terminal non-coding regions" step. can be prepared exactly like the previous example, but the only additional restriction endonuclease is Sa cI, which removes the 5' non-coding region and The charged reactive site adapter can hybridize appropriately and bind to the template strand. 5 Only restriction endonucleases specific for recognition sites in the 3'-terminal non-coding regions are used. Except for the restriction endonucleases specific for the recognition sites in the 3'-end non-coding regions, The end region remains intact, making it impossible to ligate a 3' reactive site adapter to that end. The addition of 5' charged reactive site adaptors in the step The "binding of the 3'-charged reactive site adapter" is carried out in the same manner as in Example 1. The addition of a tether is omitted. The reaction site adapter of this example is the same as that of Example 3, Example 4a. and two or more stems, two or more loops and two or more linkers as described in Example 4b. The removal of the 5'-terminal non-coding region can be carried out as described in Examples 6a and 6b. It will be appreciated by those skilled in the art that other restriction sites may be added to the 5' end of the nucleic acid sequence using the methods described herein. The terminus can be designed into the coding region and different restriction enzymes can be used for this purpose. will be understood by those skilled in the art.

[0169] Example 2b: Preparing a library with a single reactive site adapter at the 3' end of G A library with a single reactive site adapter at the 3' end of the coding strand of G was prepared. To prepare the library, the same procedure as in Example 1 was repeated except for the "removal of terminal non-coding regions" step. It is prepared in exactly the same way, with the only additional restriction endonuclease being EcoRI. This will remove the 3' non-coding region and create a 3' charged reactive site. The 3' non-coding end of the Only restriction endonucleases specific to the recognition site of the region are used to isolate the 5'-end non-coding region. If the restriction endonuclease specific for the recognition site of This step remains unattached and prevents the 5' reactive site adapter from binding to that end. Addition of 3' charged reactive site adapters, "Binding of charged reactive site adapters to libraries " is carried out in the same manner as in Example 1. The addition of the 5' charged reactive site adapter in this step is The reaction site adapters of this example are shown in Examples 3, 4a and 4b. As described in, for example, the nucleotide sequence may contain two or more stems, two or more loops, and two or more linkers. The removal of the 3'-end non-coding region as described above can be carried out using the method described in Example 6b. It will be understood by those skilled in the art that other restriction sites may be incorporated into the 3' end of the nucleic acid. that different restriction enzymes can be engineered into the coding region and used for this purpose , as will be understood by those skilled in the art.

[0170] Example 2c. Preparing libraries with reactive site adaptors ligated at different positions during synthesis One reactive site adaptor is ligated to the template oligonucleotide G, and several A building block is placed on it, and then a second reactive site adapter is attached to G. Libraries can be prepared that have two reactive site adaptors that are linked together. The method of either Example 2a or Example 2b was used. The steps of Example 1 were then repeated. One or more positional building blocks are placed using the sequence-specific hybridization method. Selection of libraries by hybridization and isolation of selected libraries from hybridization arrays "Elution of the library" and experimental procedures such as peptide coupling or peptoid coupling Chemical steps for installing the building blocks as described in Example 1 or Example The chemical steps are the same as those described in any of 10 to 32. Then, a second reaction site adaptor Removing the second terminal non-coding region ligates the second reactive site adaptor to the G. This can be done immediately before the ligation of the second reactive site adapter, which involves the removal of the second terminal non-coding region and the addition of a second reactive site adapter. A chemical step is interposed between the binding of the peptide and the site of the building block. It will be appreciated by those skilled in the art that this is possible.

[0171] Example 3: Preparing libraries with more than one reactive site per reactive site adaptor And translate.

[0172] A library having multiple reactive sites on a single adapter can be prepared as described in Example 1 or Example 4. It can be prepared in exactly the same manner as in Example 1 or 4a, except that the reaction is carried out as described in Example 1 or 4a. A reactive site adaptor hairpin having 2 (or more) bases modified with a reactive site is provided. Several configurations of the reactive site modified base are possible, e.g., at the end of the stem, Alternatively, a base arrangement having a reactive site near both reactive sites in the loop region may be used. If only one adapter is used, or if two adapters are used, Multiple reactive sites can be placed on the adapter. Such a reactive site adapter can be It is synthesized or manufactured by IDT, Coralville, Iowa, or E They are purchased from DNA oligo synthesis companies such as urofins MWG.

[0173] Example 4a: Preparation and translation of libraries with alternative hairpins at reactive site adaptors do.

[0174] Using the same protocol as described in Example 1, multiple types of hairpins were generated and various In situations where a smaller hairpin is advantageous, the stem can be as small as 5 bases. Also, the hair may include a 6-PEG linker between the complementary stem sequences. The pins can displace larger DNA loops. Durand, M., et al. " Circular dichroism studies of an oli godoxyribonucleotide containing a hairp in loop made of a hexaethylene glycol ch ain:conformation and stability.” Nucleic See Acids Research 18.21(1990):6353-6359. In cases where polydisplay is advantageous, the distance between multiple coding portions on a given hairpin may be , and the placement of those code segments is important.

[0175] The distance between the code sections can be varied and adapted to the needs of individual projects. A linker in or near the loop region of the hairpin and a linker in or near the anticode sequence. A second sequence is located at or near the anti-coding sequence of either strand of the double-stranded stem region. By providing a linker, the distance between the coding parts is increased by the number of bases constituting the stem. Similarly, the number of nucleotides in the stem can be increased or decreased to make it larger or smaller. By varying the position of the second linker along the length of the stem while keeping the By placing a linker within or near the loop region, the distance between the coding segments can be reduced. Optionally, if both linkers are located in the stem region, The number of nucleotides separating them will vary depending on the needs of the project. The linker can be placed inside the loop region, and the number of bases between them can be determined by the project. You can change it to suit your needs.

[0176] For example, a cord section arranged along a stem may be different from a cord section arranged in a loop. The placement of the coding portion on the hairpin is important when having access to different target molecules In some cases, a hairpin having multiple loops and stems is used. may have two or three loops and two stems. This hairpin may optionally have a third loop. region and then to the second strand of the first stem region, or directly to the second strand of the first stem region. a second stem region linked to a second loop region linked to a second strand of the second stem region a first loop region linked to a first strand of a first stem region linked to a first strand of a The one or more linkers may include an anti-coding region. The nucleotide sequences are located within one or more loops and one or more stem regions necessary for the synthesis of the nucleotide sequence.

[0177] Svoboda, P. et al.Cellular and Molecular Life Sciences CMLS,April 2006,Volume 63, Issue 7, pp 901-908, and Bikard,et al,Microb iology And Molecular Biology Reviews,Dec .2010, p.570-588, and Kari,et al,DNA Computi ng Volume 3892 of the series Lecture Not es in Computer Science pp 158-170, and Doma ratzki, Theory Comput Syst (2009)44:432-4 54,Brazda,et al,BMC Molecular Biology 20 11 Inner loops, bulges, and tensiles as described in 12:33 Numerous hairpin triplet structures incorporating numerous secondary structures, including but not limited to: It will be appreciated by those skilled in the art that such secondary and tertiary structures are possible. Hairpin oligos incorporating the secondary structure were obtained from Sigma-Aldrich (Integr). ated DNA Technologies (Coralville, Iowa), Euroform Synthesized by a number of DNA synthesis companies, such as INS MWG (Louisville, KY) Those skilled in the art will understand that the reaction site for attaching a linker is or modified bases having linkers and reactive sites are added to any of the hairpins during synthesis. It will be understood that the amino acid sequence may be placed in any desired location. hairpins that contain more information tend to contain longer nucleotide sequences will be understood by those skilled in the art.

[0178] Example 4b: Preparation and translation of libraries with alternative hairpins in the reaction site adaptors Translate.

[0179] Using the same protocol as described in Example 1, multiple versions of the hairpin were made. The sequence of the stem region of the reactive site adapter may be within the stem region or The restriction digest contains one or more restriction sites that allow for cleavage near the site. Allows release of very strong binders to the immobilized target, ensuring proper annealing of primers Other information is also available for the reactive site, which facilitates PCR amplification by removing the loop region that allows An example is a single-stranded adaptor hairpin DNA that is encoded by the adaptor hairpin DNA. If amplified after selection, these various bases will cause amplification bias. Or selection for artifacts may help identify enriched library members. Another example is the selection or synthesis history of a molecule, such as an index sequence, as described in Example 7. Hairpins are specific sequences that provide information about the gene's history. Hairpins can also contain fluorescently labeled bases or base pairs. The library and its synthesis or performance include analogs, radiolabeled bases or base analogs. The hairpins also have the ability to readily accept biotin-like molecules for processing, allowing for quantification and analysis of various aspects of the DNA sequence. Such hairpins may include bases having functional groups or modified bases that facilitate the synthesis of such hairpins. The materials were purchased from IDT, Sigma Aldrich, Coralville, Iowa, or Sigma Aldrich, Kentucky. A reputable supplier of specialized DNA oligos, such as Eurofins MWG of Louisville, VA. It can be purchased from.

[0180] Example 4c. Ligation of reactive site adaptors to template strands with alternative chemistries. The terminal adaptors were annealed to the terminal coding regions of the template gene, and the T4 D Ligation is performed using NA ligase. Other methods for covalently attaching reactive site adapters may be used. The charged reactive site adaptor can be attached to Shab arova, et al. (1991) Nucleic Acids Research ,19,4247-4251),Fed-erova,et al.(1996)Nuc leosides and nucleotides,15,1137-1147,Gr yaZnov,Sergei M.et al.J.Am.Chem.Soc,vol. 115:3808-3809 (1993), and Carriero and Damli a(2003) Journal of Organic Chemistry,68,8 As carried out by 328-8338, water-soluble carbodiimides and cyanogen bromide Chemical ligation is carried out using 1M glycerol at pH 7.6. 5' phosphorylated DNA was used in a buffer containing MES and 20 mM MgCl2 5M cyanogen bromide in acetonitrile, 1:10 v / v ratio, optionally performed at 0°C, 5°C, Ligation is carried out in minutes using the manufacturer's protocol with topoisomerase, It can also be carried out by means of a polymerase and a ligase.

[0181] Example 5: Preparing and translating libraries with single-stranded end coding regions.

[0182] The sterically low bulk library is constructed by arranging oligonucleotides from the terminal coding region of the reactive site adapter. Nucleotides are removed to leave the terminal coding region and optionally all or a portion of the stem region as single stranded. This is carried out exactly as in Example 1, with the following exceptions: Deoxyuridines are provided as reactive site adaptors at positions in the anticoding sequence. The nucleotide sequence is inserted within the nucleotide sequence and in the stem between the end of the anticoding region and the nearest linker. Sequence-specific hybridization and ligation of charged reactive site adapters to the template strand. After gating, the library was buffer exchanged from NEB to 1x UDG reaction buffer and reverse transcription was performed. Add 100 μl of ... The protocol involved incubation at 37°C for 30 minutes, followed by incubation at pH 12 and 95°C. The apyrimidine moiety of the hairpin was hydrolyzed by heating at 40 °C for 20 min. The sDNA fragments were purified by size exclusion using a buffer kept at 65°C. And remove it.

[0183] Example 5a. Removing oligonucleotides from the end-coding region of a reactive site adaptor This is optionally performed at some point during the conduct of Example 1. The procedure of Example 5 may be repeated with charge reversal. Addition of the first position building block after ligation of the reaction site adaptor The oligonucleotides are optionally removed in exactly the same manner as in Example 1, except that they are carried out before the After addition of the first position building block, but not after any subsequent position building block, The procedure of Example 1 was repeated except that the procedure of Example 5 was carried out prior to the addition of the binding block. In a similar manner, the oligonucleotide can be optionally removed. , except that the procedure of Example 5 is carried out after the addition of every position building block. The DNA strand can be cut at a desired position by optionally removing the fragment, exactly as in Example 1. This can be accomplished in a number of ways, and there are a number of commercially available enzymes and enzyme replacements that facilitate this task. Those skilled in the art will recognize that there are published protocols for New England Biolabs has developed a method to detect nicking endonucleases containing at least 10 The company sells ELISA kits and publishes protocols for their use. The specific example shown here is The following is an exemplary procedure for generating terminal coding regions and, optionally, a portion of a hairpin single strand: It is not intended to exclude other ways of achieving this.

[0184] Example 6a: UDG is used to remove the 5' non-coding region.

[0185] The restriction digest used to remove the 5' non-coding region in Example 1 was eliminated, and the UD G and subsequent alkaline hydrolysis of the apyrimidine moiety. The primers are prepared exactly as in Example 1, except that the oligos priming the reverse transcription are Incorporates a dU base at or near the 3' end of the primer. Reverse transcription and base hydrolysis of the RNA strand. After digestion, UDG removes uracil and prepares the DNA for ligation of the charged reactive site adapter. The use of heat and alkali (UDG and reaction conditions) to produce a terminal coding region that is ready for (see Example 5) can be used to create an apyrimidinic site that is subsequently cleaved. There are numerous methods to make single or double strand breaks in DNA at desired locations that can facilitate this task. Those of skill in the art will appreciate that there are numerous commercially available enzymes and published protocols that facilitate The specific examples shown here are merely illustrative and are intended to be used for the purpose of removing the 5' non-coding region. This does not exclude other ways of achieving this.

[0186] Example 6b: Restriction enzyme NdeI is used to cleave the 5'-end non-coding region or the 3'-end non-coding region Remove the area.

[0187] Used to remove the 5' end coding region, the 3' end coding region, or both The restriction digestion used is to include a recognition site for NdeI in the terminal non-coding region and to This is achieved by a restriction digest followed by a step of cleavage. NdeI has It has the function of cleaving the lid and the function of cleaving single-stranded DNA. It is used to cleave the NA chain either before or after base hydrolysis, or both. can be.

[0188] Example 6c: Removing the 5'-end non-coding region using the RNA base of the reverse transcription primer The 5'-end non-coding region is the primer used in the "reverse transcription of RNA into DNA" process. The DNA is removed using the exact protocol of Example 1, except that the nucleotide sequence contains an RNA base. As in Example 1, when the RNA strand of the reverse transcription product is hydrolyzed, the RNA in the DNA primer The A base is also hydrolyzed, removing the portion of the DNA primer that is 5' to the RNA base.

[0189] Example 7: Index molecules of formula (I).

[0190] The code region is either reserved or added for use as an index region. After library preparation and translation as in Example 1, the library was subjected to hybridization. On the application array, the code regions reserved for indexing are classified. The subpools generated by such selection can be used for different purposes and Different properties, different targets, or different conditions for selecting against the same target. The products are optionally amplified independently by PCR and repooled with other subpools, as in Example 1. It will be retranslated as 1.

[0191] Example 8a: Gene libraries are prepared by alternative methods.

[0192] Example 1 shows the restriction deletion in all internal non-coding regions of the provided library gene sequences. The combinatorial reassembly of all codons simultaneously was achieved by ligation followed by This process is optionally performed in stages rather than simultaneously. Except that instead of a nuclease, a single restriction endonuclease is added. "DNA that has been restriction digested to disassociate all codons from each other" in Example 1 The same reaction conditions as in step 1 are used. The reaction conditions were the same as those found in the "Generating a Gene Library by Real-time Reassembly" process. The ligation products are then religated together. The DNA is purified, amplified by PCR, and cut with the following restriction enzymes: Repeat until the whole thing is complete.

[0193] Example 8b: Alternative method for preparing gene libraries.

[0194] Examples 1 and 8a show restriction digestion and subsequent ligation in all internal non-coding regions. In some embodiments, the present invention describes a combinatorial reassortment of all codons by a single codon sequence. , incomplete combinatorial reordering of codons to generate populations with significantly lower complexity Such a gene library may be advantageously assembled from the 96 genes described in Example 1. The mixture of child sequences is produced by dividing it into several aliquots. Each The aliquots were subjected to the "DNA restriction digest to disassociate all codons from each other" procedure described in Example 1. Using steps 1-3, or the reaction conditions found in Example 8a, different combinations of restriction enzymes After heat inactivation of the restriction enzyme, the separate digestion products are digested according to step Example 1. The gene library was constructed by combinatorial reassembly of codons using the protocol described in The products are pooled, purified by agarose gel electrophoresis, and amplified by PCR. Amplification and the remaining library preparation and translation and selection are carried out according to Example 1.

[0195] Example 8c: Gene shuffling or cross-reaction is performed on the library. Translate and select a library such as that described in Example 1 or Example 8a or Example 8b. Then, gene shuffling is performed to extract genes that were not previously present in the library. A progeny table in which new progeny phenotypes are produced or phenotypes that survived selection are resampled. The mutants are then generated. After selection the library is amplified by PCR. Divide the mixture into several aliquots and aliquot each according to the protocol described in Example 8 or any other suitable method. The DNA is subjected to restriction digestion to isolate all codons. The codons are then decoupled and combinatorially reassembled to create a gene library. The digestion / religation products are pooled as described in Example 1 or 8b. , purified and amplified, and subsequent rounds of library preparation, translation and selection were performed as described in Example 1. Follow the instructions.

[0196] Example 9: Preparing and translating libraries with alternative reactive site functional groups and linkers .

[0197] Libraries with different initial reactive sites from free amines can be generated in several ways. One method is to convert an existing initial reactive site functional group into a compound having the desired initial reactive site functional group. The first step is to cap the reactive site adapter with a bifunctional molecule that is charged. In step ", different peptide coupling reaction conditions are used to couple the peptides. Each reactive site adaptor where an initial reactive site is desired, a peptide bond is The initial reactive site functional group is formed on the amine with a bifunctional compound having an initial reactive site functional group. The library is prepared exactly as in Example 1, except that 5-hydroxybutyric acid is used. The library was synthesized by reacting oxypentanoic acid with free amines to form peptide bonds. Hydroxyl functionality can be created as the initial reaction site for the synthesis of aryl esters.

[0198] The second method involves the use of alternative methods that allow or facilitate the introduction of other desired initial reactive site functional groups. The goal is to incorporate different bases modified at different reactive sites. One such base is bar 5-Ethynyl-dU-C sold by Glen Research, Zinnia It is an E phosphoramidite (“ethynyl-dU”). This is optionally modified with a bifunctional linker compound having an azide and a desired initial reaction site functional group. For example, 5-azidopentanoic acid is reacted with the alkynyl moiety in a “click” reaction (Huisgen reaction) under the conditions found in Example 25 to establish a carboxylic acid as the first reaction site functional group. As another representative but non-inclusive example, 5-azido-1-pentanal can react with the alkynyl moiety in a “click” reaction (Huisgen reaction) to create an aldehyde as the initial reaction site functional group. As another representative example, 4-azido,1-bromomethylbenzene can be reacted with the alkynyl moiety in a “click” reaction (Huisgen reaction) to create a benzyl halide as the initial reaction site functional group. This base is optionally used as an alkynyl initial reaction site for library synthesis using chemical properties suitable for the alkynes selected from Examples 10 - 33. Desirable initial reaction sites include, but are not limited to, amines, azides, carboxylic acids, aldehydes, alkenes, acryloyl groups, benzyl halides, halides at the α-position of carbonyl groups, and 1,3-dienes.

[0199] The third method is to incorporate a base modified with both a linker and an initial reaction site functional group during the synthesis of the reaction site adapter hairpin. For example, 5’-dimethoxytrityl-N6-benzoyl-N8-[6-(trifluoroacetylamino)-hex-1-yl]-8-amino-2’-deoxyadenosine-3’-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite (Glen R of Sterling, Virginia) ​​​​​​​​​​ The amino-modifier C6dA, purchased from esearch, was used for the synthesis of hairpin When incorporated at a critical position in the As a C6 alkyl chain, 5'-dimethoxytrityl-N2-[6-(trifluoromethyl) 2'-deoxyguanosine-3'-[(2-acetylamino)-hex-1-yl] Cyanoethyl)-(N,N-(diisopropyl)]-phosphoramidite (amino modifier C Also known as 6dG, purchased from Glen Research, Sterling, Virginia) 5'-Dimethoxytrityl-5-[3-methyl-acrylate] -2'-Deoxyuridine, 3'-[(2-cyanoethyl)-(N,N-diisopropyl )]-phosphoramidite (also called Carboxy dT, Sterling, VA) (purchased from Glen Research, Inc.) was inserted at a critical position during the synthesis of the hairpin. When inserted, it creates a carboxylic acid as the first reactive site functional group and a two-carbon chain as the linker. 5'-Dimethoxytrityl-5-[N-((9-fluorenylmethoxycarbo Nyl)-aminohexyl)-3-acrylimido]-2'-deoxyuridine, 3'-[ (2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite (Fmoc- Amino Modifier C6dT, also known as C6dT, Glen Research, Sterling, Virginia rch) at a critical position during the synthesis of the hairpin, providing the initial reactive site functional group. Then, using Fmoc-protected amine as the linker, we will make a 6-carbon chain. Trityl-5-(octa-1,7-diaminodiphenyl)-2'-deoxyuridine, 3'-[(2 -Cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite (C8alkyn e dT, also known as Sterling VA Glen Research) When incorporated at a critical position during the synthesis of the pin, the alkyne serves as the first reactive site functional group. would create an 8 carbon chain as a linker. 5'-(4,4'-dimethoxytrityl) -5-[N-(6-(3-benzoylthiopropanoyl)-aminohexyl)-3-acyl 3'-[(2-cyanoethyl)-(N,N-diamino)-2'-deoxyuridine isopropyl)]-phosphoramidite (also called S-Bz-thiol modifier C6-dT) Glen Research, Sterling, Virginia, for the synthesis of hairpins. The incorporation of the thiol as the first reactive site functional group and the thiol as the linker functional group at the first critical position allows The N4-TriGl will be placed at a critical position during the synthesis of the hairpin. -amino 2'-deoxycytidine (from IBA GmbH, Gottingen, Germany) was The incorporation of amines as the first reactive site functional group and 3-ethylene glycol as the linker results in This will create a chain of tetracycline units.

[0200] Suitable linkers are those that (i) covalently attach the hairpin to the building block; and (ii) they do not interfere with other important functions in the synthesis or use of the molecules of formula (I). Thus, in some embodiments, the linker are alkyl or PEG chains because (a) they are highly flexible and easy to select; (b) to present the coding portion appropriately and freely on the target molecule during the This is because they are chemically inert and do not usually undergo side reactions during the synthesis of the molecules of formula (I). For most, but not all, tasks to work properly, the linker should be longer than about 8 PEG units. It is not necessary that the library DNA contain the entire length of the target molecule or target structure or target surface. If selection is performed, the linker must be kept as far away as possible from the and / or a fairly rigid linker such as a peptide α-helix would be useful and attractive. It will be appreciated by those skilled in the art that other desirable linkers include polyglycine. , polyalanine, or polypeptide. The fullerenes used to bind the molecules of formula (I) in a manner or complementary to the binding of the coding portions. Linkers incorporating heterophores, radiolabels, or functional moieties may also be used. In some situations, it is possible to incorporate biotin into the linker to immobilize the library. It may be necessary to have a code that can bind to a second binding pocket of the same target molecule. As a means of selecting the dopant moiety, a known ligand is incorporated into one of the binding pockets of the target molecule. It may also be useful to include

[0201] The library contains different linkers and different chemistries on different reactive site adaptors. One or more linkers on the 5' reactive site adapter may be used to optionally prepare can have one type of linker and one type of reactive site functional group; The 3' reactive site adaptors may have different linkers and the same reactive site functional group or may have different The linkers and functional groups named herein are If the chemistry required for the subsequent introduction of a positional building block is 1. The functional groups of the building block D and the second building block E are matched to each other. Any compound that reacts with the reactive site functional groups on each hairpin is suitable for use in this example. be.

[0202] This compatibility can be in two ways. In the first way, different chemical properties can be found in the reactive site adaptors. The first building block D and the second building block D are used to charge the photodiode. Both of the cyclic blocks E and E undergo the same chemical transformation in the next or subsequent downstream steps. In the second format, different chemistries can be used to charge the reactive site adaptors. In this second format, new A functional group on the 5' coding portion, a functional group on the next position building block for the 5' end, and and the chemistry used for coupling is determined based on the functionality present on the nascent 3' coding portion. Similarly, this second format requires that the nascent 3' coding portion be non-reactive with the nucleotide group. the functional group on the 3'-terminus, the functional group on the next position building block for the 3'-terminus and its coupling The chemistry used for the tagging must be non-reactive with the functional groups present in the nascent 5' coding region. Building blocks using orthogonal chemistry on the 3' and 5' reactive site adapters are required. The steps of introducing the lock may be performed in any order. Furthermore, at any given stage of the synthesis, Among the various building blocks introduced, the introduction of any one of them Those skilled in the art will understand that what is not done is an important diversity factor. Suitable chemistries for this step include, but are not limited to, those described in Examples 10-32 and and the chemistry described in Example 1.

[0203] Example 10: The coding portion is synthesized using Suzuki coupling chemistry.

[0204] Building on a charged reactive site adaptor as a reactive site on a reactive site adaptor Contains aryl iodides either as blocks or as partially translated molecules. The DNA library to be purified is dissolved in 1 mM water. 50 equivalents of boronic acid as a 0 mM stock solution, 300 equivalents of charcoal as a 200 mM aqueous solution sodium phosphate, 20 equivalents of 3,3',3''-phosphanetriyltris(benzenesulfonyl) Trisodium salt of 100 mM phosphate in dimethylacetamide premixed 0.8 equivalents of palladium acetate as a 10 mM stock solution was added. The mixture was incubated at 65°C. The DNA library is then purified by ethanol precipitation. Dissolve the solution to 1 mM, add 120 equivalents of sodium sulfide to make a 400 mM aqueous solution, and heat at 65°C for 1 The product was diluted to 200 μl with dH2O and subjected to ion exchange chromatography. (Gouliaev, AH, Franch, TPO, Gods kesen, MA, and Jensen, KB (2012) Bi-funct ional Complexes and methods for making a nd using such complexes. Patent application WO2011 / 12793 (See 3A1).

[0205] Example 11: The coding portion is synthesized using Sonogashira coupling chemistry.

[0206] Building on a charged reactive site adaptor as a reactive site on a reactive site adaptor Contains aryl iodides either as blocks or as partially translated molecules. The DNA library to be prepared is dissolved in 1 mM water. 100 equivalents of alkyne as 0 mM stock solution, 200 mM in dimethylacetamide Stock solution: 300 equivalents of pyrrolidine, 10 mM stock in dimethylacetamide 0.4 equivalents of palladium acetate as a 100 mM solution, 2 equivalents of 3,3', 3''Phosphantriyltris(benzenesulfonic acid) trisodium salt was added. 6 After reacting at 5°C for 2 hours, the product was purified by ethanol precipitation or ion exchange chromatography. make ((1)Liang, B., Dai, M., Chen, J., and Yang ,Z.(2005)Cooper-free sonogashira couplin g reaction with PdCl2 in water under aer obic conditions.J.Org.Chem.70,391-393;(2 )Li, N., Lim, RKV, Edwardraja, S., and Lin, Q.(2011)Copper-free Sonogashira cross-co upling for functionalization of alkyne e encoded proteins in aqueous medium and in bacterial cells.J.Am.Chem.Soc.133,15316 -15319;(3)Marziale, AN, Schliiter, J., and Eppinger, J. (2011) An efficient protocol for copper-free palladium-catalyzed Sono gashira crosscoupling in aqueous media a t low temperatures.Tetrahedron Lett.52,6 355-6358;(4) Kanan, MW, Rozenman, MM, Sak urai, K., Snyder, T. M., and Liu, D. R. (2004)Re. action discovery enabled by DNA-template d synthesis and in vitro selection.Natural e 431, 545-549).

[0207] Example 12: Synthesis of the coding portion using carbamylation.

[0208] The reactive sites on the reactive site adaptor are the building blocks on the charged reactive site adaptor. DNA libraries with amines either as locks or as partially translated molecules Dissolve 1 mM of glycerol in water. Add 1:4 v / v triethylamine, dimethylamine, 50 equivalents of di-2-pyridyl carbonate as a 200 mM stock solution in acetamide After 2 hours at room temperature, add 200 mM stock in dimethylacetamide. Add 40 equivalents of the amine as a solution for 2 h at room temperature. The product is precipitated with ethanol or ionized. The product is purified by exchange chromatography. I., and Fochi, R. (2007) Preparation of mono -,di-,and trisubstituted ureas by carbon ylation of aliphatic amines with S,S-dim ethyl dithiocarbonate.Synthesis 22,3497- 3506;(2) Franch, T., Lundorf, MD, Jacobsen, SN, Olsen, EK, Andersen, AL, Holtmann, A .,Hansen,A.H.,Sorensen,A.M.,Goldbech,A., De Leon,D.,et al.Enzymatic encoding meth ods for efficient synthesis of large lib raries. See WIPO WO2007 / 062664 A2, 2007).

[0209] Example 13: Synthesis of coding parts using thioureation Complete.

[0210] The reactive sites on the reactive site adaptor are the building blocks on the charged reactive site adaptor. DNA libraries with amines either as locks or as partially translated molecules Dissolve the 1 mM glycerol in water. Add this to a 200 mM stock in dimethylacetamide. 20 equivalents of 2-pyridylthionocarbonate are added as a solution for 30 minutes at room temperature. 40 equivalents of amine as a 200 mM stock solution in dimethylacetamide at room temperature Add 100 ml of ethanol, warm slowly to 60 μC, and react for 18 hours. Purify by ion exchange chromatography. (Deprez-Poulain, R. F., Charton, J., Leroux, V., and Deprez, BP( 2007)Convenient synthesis of 4H-l,2,4-tr iazole-3-thiols using di-2-pyridylthiono carbonate.Tetrahedron Lett.48,8157-8162 reference).

[0211] Example 14: The coding portion is synthesized using reductive monoalkylation of an amine.

[0212] The reactive sites on the reactive site adaptor are the building blocks on the charged reactive site adaptor. DNA labels with amines, either as locks or as partially translated molecules, The library was dissolved in 1 mM water. This was supplemented with 200 mM stock solution in dimethylacetamide. Add 40 equivalents of aldehyde as a base and react at room temperature for 1 hour. Then, add 40 equivalents of water. Sodium borohydride was added as a 200 mM stock solution in acetonitrile and incubated at room temperature. The product was precipitated with ethanol or purified by ion exchange chromatography. (Abdel-Magid, AF, Carson, KG, Harri S, BD, Maryanoff, CA, and Shah, RD (1996 )Reductive amination of aldehydes and ke tones with sodium triacetoxyborohydride. (See J. Org. Chem. 61, 3849-3862).

[0213] Example 15: Synthesis of coding moieties using SNAr with heteroaryl compounds.

[0214] The reactive sites on the reactive site adaptor are the building blocks on the charged reactive site adaptor. DNA labels with amines, either as locks or as partially translated molecules, The library was dissolved in 1 mM water and diluted with 200 mM stock solution in dimethylacetamide. 60 equivalents of a heteroaryl halide was added as a base and the reaction was carried out at 60°C for 12 hours. The product is purified by ethanol precipitation or ion exchange chromatography. ch, T., Lundorf, MD, Jacobsen, SN, Olsen, E. K., Andersen, A.L., Holtmann, A., Hansen, A.H. .,Sorensen,A.M.,Goldbech,A.,De Leon,D.,e t al.Enzymatic encoding methods for effi cient synthesis of large libraries.WIPO (see WO 2007 / 062664 A2, 2007).

[0215] Example 16: Synthesis of coding regions using Horner-Wadsworth-Emmons chemistry Combine the minutes.

[0216] The reactive sites on the reactive site adaptor are the building blocks on the charged reactive site adaptor. DNA with aldehydes either as lock or as partially translated molecules The A library is dissolved in 1 mM borate buffer, pH 9.4. 50 equivalents of ethyl 2-(diethoxyphosphoryl)acetamide as a 200 mM stock Acetate and 50 equivalents of cesium carbonate as a 200 mM aqueous solution were added, and the mixture was stirred for 16 h at room temperature. The reaction is allowed to proceed for 2 h. The product is purified by ethanol precipitation or ion exchange chromatography. do. (Manocci, L., Leimbacher, M., Wichert, M., Scheuermann, J., and Neri, D. (2011) 20 years of DNA-encoded chemical libraries.Chem. (See Commun. 47, 12747-12753).

[0217] Example 17: Synthesis of the coding portion using sulfonylation.

[0218] The reactive sites on the reactive site adaptor are the building blocks on the charged reactive site adaptor. DNA libraries with amines either as locks or as partially translated molecules The lysate is dissolved in 1 mM borate buffer (pH 9.4). Add 40 equivalents of sulfonyl chloride as a 200 mM stock solution in water and incubate at room temperature for 16 hours. The product is purified by ethanol precipitation or ion exchange chromatography. . (Franch, T., Lundorf, MD, Jacobsen, SN, O lsen, E. K., Andersen, A. L., Holtmann, A., Hans. en, A.H., Sorensen, A.M., Goldbech, A., De Leo. n,D.,et al.Enzymatic encoding methods fo efficient synthesis of large libraries (See WIPO WO2007 / 062664 A2, 2007).

[0219] Example 18: Synthesis of the coding portion using trichloro-nitro-pyrimidine.

[0220] The reactive sites on the reactive site adaptor are the building blocks on the charged reactive site adaptor. DNA libraries with amines as locks or as partially translated molecules Dissolve in 1 mM borate buffer, pH 9.4. Add 2 mM of dimethylacetamide to this. 20 equivalents of trichloro-nitro-pyrimidine (TCNP) as a 5,000 mM stock solution The reaction is allowed to warm to room temperature over 1 hour and purified by ethanol precipitation. The DNA library was dissolved at 1 mM in borate buffer pH 9.4 and 40 equivalents of amines were added. 200 mM stock solution in dimethylacetamide, 100 equivalents of pure triethylamine Add 500 mM NaCl and incubate at room temperature for 2 hours. The library is purified by ethanol precipitation. The DNA library can be dissolved immediately in borate buffer for immediate reaction or can be prepared by pre-dissolving. The DNA was then collected, reselected on the array, dissolved in borate buffer, and diluted in dimethylacetamide. A 200 mM stock was reacted with 50 equivalents of amine and 100 equivalents of triethylamine. The reaction was allowed to proceed at room temperature for 24 hours. The product was precipitated with ethanol or purified by ion exchange chromatography. (Roughley, S.D., and Jordan, AM (2011) The medicinal chemist's too lbox: an analysis of reactions used in t he pursuit of drug candidates. J. Med. C (see hem. 54, 3451-3479).

[0221] Example 19: Synthesis of the coding portion using trichloropyrimidine.

[0222] The reactive sites on the reactive site adaptor are the building blocks on the charged reactive site adaptor. DNA labels with amines, either as locks or as partially translated molecules, The library is dissolved in 1 mM borate buffer, pH 9.4. This is diluted with 200 mM DMA. Add 50 equivalents of 2,4,6 trichloropyrimidine as a stock solution and dilute it at room temperature for 3.5 h. The DNA was precipitated in ethanol and then added to a borate buffer at pH 9.4. Redissolve at 1 mM. Add 40 equivalents of amine as a 200 mM stock in acetonitrile. The product is purified by ethanol precipitation. The DNA library is then immediately dissolved in borate buffer for immediate reaction, or After pooling and reselection on the array, the proteins were dissolved in borate buffer and diluted with dimethylacetamide (DMPA). 60 equivalents of boronic acid as a 200 mM stock in MA and as a 500 mM aqueous solution 200 equivalents of sodium hydroxide, 2 equivalents of paraacetate as a 10 mM DMA stock 20 equivalents of tris(3-sulfophenyl)phosphine as a 100 mM aqueous solution The DNA was reacted with ATPase trisodium salt (TPPTS) at 75°C for 3 hours. The solution was precipitated in methanol and then dissolved in water at 1 mM and made into a 400 mM stock in water at 1 The mixture was reacted with 20 mM sodium sulfide at 65°C for 1 hour. The product was precipitated with ethanol or lyophilized. Purify by ion-exchange chromatography.

[0223] Example 20: The coding part is synthesized using Boc-deprotection.

[0224] The reactive sites on the reactive site adaptor are the building blocks on the charged reactive site adaptor. DNA labels with Boc-protected amines as locks or as partially translated molecules The library was dissolved at 0.5 mM in borate buffer (pH 9.4) and heated at 90°C for 16 hours. The product was purified by ethanol precipitation, size exclusion chromatography or ion exchange chromatography. (Franch, T., Lundorf, MD, Ja cobsen,SN,Olsen,EK,Andersen,AL,Hol tmann, A., Hansen, A.H., Sorensen, A.M., Goldb. ech,A.,De Leon,D.,et al.Enzymatic encodi ng methods for efficient synthesis of la rge libraries. See WO2007 / 062664A2, 2007.)

[0225] Example 21: The coding portion is synthesized using hydrolysis of t-butyl esters.

[0226] The reactive sites on the reactive site adaptor are the building blocks on the charged reactive site adaptor. DNA with t-butyl esters as locks or as partially translated molecules The library is dissolved in 1 mM borate buffer and reacted at 80°C for 2 hours. Ethanol precipitation, size exclusion chromatography or ion exchange chromatography (Franch, T., Lundorf, MD, Jacobsen, S N., Olsen, E. K., Andersen, A. L., Holtmann, A. ,Hansen,A.H.,Sorensen,A.M.,Goldbech,A.,D. e Leon,D.,et al.Enzymatic encoding method ds for efficient synthesis of large libr aries. WIPO WO2007 / 062664A2, 2007.)

[0227] Example 22: Synthesize the encoded portion using Alloc-deprotection.

[0228] The reactive sites on the reactive site adaptor are the building blocks on the charged reactive site adaptor. DNA with Alloc-protected amines as locks or as partially translated molecules The A library is dissolved at 1 mM in borate buffer at pH 9.4. 10 equivalents of palladium tetrakistriphenylphosphine as DMA stock, 200 Add 10 equivalents of sodium borohydride as a mM stock in acetonitrile and immerse at room temperature. The reaction was allowed to proceed for 2 hours. The product was purified by ethanol precipitation or ion exchange chromatography. (Beugelmans, R., Neuville, MB-C, Chast anet, J., and Zhu, J. (1995) Palladium catalyst zed reductive deprotection of Alloc:Tran protection and peptide bond formation.T (See etrahedron Lett.36,3129)

[0229] Example 23: The coding portion is synthesized using methyl / ethyl ester hydrolysis.

[0230] The reactive sites on the reactive site adaptor are the building blocks on the charged reactive site adaptor. With methyl or ethyl esters as locks or as partially translated molecules The DNA library was dissolved in 1 mM borate buffer and incubated at 60° C. with 100 equivalents of NaOH. The reaction was continued for 2 hours at 4°C for 2 h. The products were purified by ethanol precipitation, size exclusion chromatography, or ion exchange. The product is purified by ion exchange chromatography. (Franch, T., Lundorf, M. D., Jacobsen, S.N., Olsen, E.K., Andersen, A. L., Holtmann, A., Hansen, A.H., Sorensen, A.M. ,Goldbech,A.,De Leon,D.,et al.Enzymatic encoding methods for efficient synthesis of large libraries.WIPO WO2007 / 062664 A 2, 2007)

[0231] Example 24: Synthesis of the coding portion using reduction of the nitro group.

[0232] The reactive sites on the reactive site adaptor are the building blocks on the charged reactive site adaptor. DNA libraries with nitro groups as locks or as partially translated molecules The 10% volume equivalent of Raney nickel slurry, 10% volume equivalent of 10% ammonium chloride, and 10% volume equivalent of 10% ammonium chloride were dissolved in water. Add an equivalent amount of hydrazine as a 400 mM aqueous solution and shake at room temperature for 2 to 24 hours. The product was purified by ethanol precipitation or ion exchange chromatography. . (Balcom, D., and Furst, A. (1953) Reductions with hydrazine hydrate catalyzed by Ran (See E. Y. Nickel. J. Am. Chem. Soc. 76, 4334-4334) .

[0233] Example 25: The coding portion is synthesized using "click" chemistry.

[0234] The reactive sites on the reactive site adaptor are the building blocks on the charged reactive site adaptor. DNA with alkyne or azide groups as locks or as partially translated molecules Library A is dissolved in 100 mM phosphate buffer. 625 μL of copper sulfate is added to the solution. M, THPTA (ligand) 3.1 mM, amino-guanidine 12.5 mM, Asco 12.5 mM sorbic acid, and 1 mM azide (if the DNA contained an alkyne) or azide. Add 1 mM azide (if the DNA contains an azide). The reaction is carried out at room temperature for 4 hours. The product was subjected to ethanol precipitation, size exclusion chromatography or ion exchange chromatography. (Hong, V., Presolski, Stanislav I. , Ma, C. and Finn, M. G. (2009), Analysis and O. optimization of Copper-Catalyzed Azide- A lkyne Cycloaddition for Bioconjugation.A ngewandte Chemie International Edition,4 8:9879-9883).

[0235] Example 26: Synthesis of coding segments incorporating benzimidazole.

[0236] The reactive sites on the reactive site adaptor are the building blocks on the charged reactive site adaptor. Having aryl vicinal diamines as locks or as partially translated molecules The DNA library is dissolved at 1 mM in borate buffer at pH 9.4. Add 60 equivalents of aldehyde as DMA stock (mM) and react at 60°C for 18 hours. The product is purified by ethanol precipitation or ion exchange chromatography. )Mandal, P., Berger, S. B., Pillay, S., Moriwak. i, K., Huang, C., Guo, H., Lich, J. D., Finger, J. K. asparcova, V., Votta, B., et al. (2014) RIP3 i induces apoptosis independent of pronecrops tic kinase activity.Mol.Cell 56,481-495; (2) Gouliaev, AH, Franch, TP-O., Godskese n, MA, and Jensen, KB (2012) Bi-functiona. l Complexes and methods for making and u sing such complexes.Patent application WO2011 / 127933 Al (3) Mukhopadhyay, C, and Tapaswi, PK (2008 )Dowex 50W: A highly efficient and recycl able green catalyst for the construction of the 2-substituted benzimidazole moie ty in aqueous medium.Catal.Commun.9,2392 -2394).

[0237] Example 27: Synthesis of coding segments incorporating imidazolidinone.

[0238] The reactive sites on the reactive site adaptor are the building blocks on the charged reactive site adaptor. With alpha-amino-amide as lock or as partially translated molecule The DNA library was dissolved at 1 mM in 1:3 methanol:borate buffer at pH 9.4. To this was added 60 equivalents of aldehyde as a 200 mM DMA stock, and the mixture was heated at 60°C. The reaction was allowed to proceed for 18 hours. The product was isolated by ethanol precipitation or ion exchange chromatography. (1) Barrow, JC; Rittle, KE; Ngo, PL .,Selnick,HG,Graham,SL,Pitzenberger,S M., McGaughey, G. B., Colussi, D., Lai, M.-T., Huang,Q.,et al.(2007)Design and synthesis s of 2,3,5-substituted imidazolidin-4-on e inhibitors of BACE-1.Chem.Med.Chem.2,9 95-999;(2)Wang,X.-J,Frutos,RP,Zhang,L. ,Sun,X.,Xu,Y.,Wirth,T.,Nicola,T.,Nummy,L .J,Krishnamurthy,D.,Busacca,C.A.,Yee,N., and Senanayake, CH (2011) Asymmetric synt. hesis of LFA-1 inhibitor BIRT2584 on met ric ton scale.Org.Process Res.Dev.15,118 5-1191;(3) Blass, BE, Janusz, JM, Wu, S., R idgeway, JMII, Coburn, K., Lee, W., Fluxe, A. J.,White,RE,Jackson,CM,and Fairweath er,N.4-Imidazolidinones as KV 1.5 Potass ium channel inhibitors.WIPO WO2009 / 07962 4 A1, 2009).

[0239] Example 28: Synthesis of coding segments incorporating quinazolinones.

[0240] The reactive sites on the reactive site adaptor are the building blocks on the charged reactive site adaptor. 2-anilino-1-benzamide as a lock or as a partially translated molecule The DNA library containing the nucleotide sequence is dissolved at 1 mM in borate buffer at pH 9.4. 200 equivalents of NaOH as a 1M solution in water, and A as a 200 mM stock solution in DMA. Add aldehyde and react at 90℃ for 14 hours. The product is precipitated with ethanol or ion-exchanged. The product is purified by exchange chromatography (Witt, A., and Bergmann, J. (2000) Synthesis and reactions of some 2-vinyl-3H-quinazolin-4-ones.Tetrahedron 56,7245-7253).

[0241] Example 29: Synthesis of coding segments incorporating isoindolinones.

[0242] The reactive sites on the reactive site adaptor are the building blocks on the charged reactive site adaptor. DNA libraries with amines as locks or as partially translated molecules Dissolve in 1 mM borate buffer, pH 9.4. Add 200 mM stop Add 4-bromo, 2-enemethyl ester as a solution and react at 60°C for 2 hours. The product is purified by ethanol precipitation or ion exchange chromatography. uleta, C., Croixa, C., Alagillea, D., Normand, S. ,Delwailb,A.,Favotb,L.,Lecronb,J.-C,and Viaud-Massuarda,MC(2011)Design,synthes is and biological evaluation of new thal idomide analogues as TNF-α and IL-6 prod uction inhibitors.Bioorg.Med.Chem.Lett.2 (see 1,1019-1022).

[0243] Example 30: Synthesis of coding moieties incorporating thiazoles.

[0244] The reactive sites on the reactive site adaptor are the building blocks on the charged reactive site adaptor. DNA libraries with thiourea as lock or partially translated molecules Dissolve 1 mM in borate buffer, pH 9.4. Add 200 mM stop Add 50 equivalents of bromoketone as a base and react at room temperature for 24 hours. The product is purified by ethanol precipitation or ion exchange chromatography. (Potewar, T. M., Ingale, S.A., and Srinivasan, K.V. (2008) Catalyst-free efficient synthesis is of 2-aminothiazoles in water at ambie nt temperature. Tetrahedron 64,5019-5022 (see

[0245] Example 31: Synthesis of coding segments incorporating imidazopyridines.

[0246] The reactive sites on the reactive site adaptor are the building blocks on the charged reactive site adaptor. The aryl aldehydes are either used as locks or as partially translated molecules. The DNA library to be purified is dissolved in 1 mM borate buffer at pH 9.4. 50 equivalents of 2-aminopyridine was added as a 200 mM stock solution in MA, and 1 Add 2500 equivalents of NaCN as M aqueous solution and react at 90°C for 10 hours. Product The product is purified by ethanol precipitation or ion exchange chromatography. ((1) Alex ander Lee Satz,Jianping Cai,Yi Chen,Robe rt Goodnow, Felix Gruber, Agnieszka Kowalc zyk, Ann Petersen, Goli Naderi-Oboodi, Lucj a Orzechowski,and Quentin Strebel.DNA Co mpatible Multistep Synthesis and Applica tions to DNA Encoded Libraries Bioconjug ate Chemistry 2015 26(8),1623-1632;(2)Be atch, GN, Liu, Y., and Plouvier, BMCPCT Int. Appl.2001096335,Dec 20,2001;(3)Ingl is,SR,Jones,RK,Booker,GW,and Pyke,S .M. (2006) Synthesis of N-benzylated-2-ami noquinolines as ligands for the Tec SH3 See domain.Bioorg.Med.Chem.Lett.16,387-390. see).

[0247] Example 32: The encoded moieties are synthesized using a variety of alternative chemistries.

[0248] 31 types of compatible chemical reactions are included in the Handbook for DNA-Encoded ed Chemistry(Goodnow RA, Jr.,Ed.)pp 319 -347, 2014 Wiley, New York. SNAr reaction of lychlorotriazines, oxidation of diols to glyoxal compounds, Msec Deprotection, Ns deprotection, Nvoc deprotection, pentenoyl deprotection, indole-styrene coupling Pring, Diels-Alder reaction, Wittig reaction, Michael addition, Heck reaction, Henry reaction, 1,3-dipolar cycloaddition of nitrones with cassyl alkenes, oxazolidinyl formation of azine, trifluoroacetamide deprotection, alkene-alkyne oxidative coupling, These include ring-closing metathesis and aldol reactions. They may function in the presence of DNA. and other reactions suitable for use are listed in this reference.

[0249] Example 33: Using different restriction enzymes in library preparation. The restriction enzymes listed in the other examples are representative, and other restriction enzymes may be suitable or have other advantages. It will be appreciated that a similar purpose may be achieved by using a

[0250] Example 34. Another method for preparing a gene library. Libraries are prepared that contain the code regions. With the following exceptions, the libraries are The library is prepared and translated according to Example 1. The library consists of two sets of oligos, the coding strand of the oligos, Each set is constructed by purchasing a set of oligos and anticode strands. , which contains as many subsets as there are coding regions, and which contains different coding sequences in the coding regions. There are as many different sequences in each subset as there are in each subset of coding strand oligos. Each oligo comprises a coding sequence and optionally a 5' non-coding region. Each oligo in each subset contains an anticoding sequence and, optionally, a 5' non-coding region complement. To facilitate downstream ligation in this process, the coding strand and the amplicon may be All oligos except the oligo at the 5' end of the coding strand were purchased as 5' phosphorylation or The 5' coding strand is phosphorylated with T4 PNK from NEB according to the manufacturer's protocol. The subset of oligos with terminal coding sequences are those with 3' terminal anticoding sequences. The two sets were combined in T4 DNA Ligase buffer from NEB. This results in a single-stranded 5' overhang on the coding strand. The non-coding region, the double-stranded coding region, and any single-stranded 5' overhangs on the non-coding strand. This hybridization procedure produces products that contain non-coding regions. For example, the second coding / non-coding pair from the 5' end is The subset of sequences encoding the coding region of the and a subset encoding the third coding region from the end of the Hybridized subset pairs are pooled and optionally subjected to agarose gel electrophoresis. The gene in the library has a non-coding region of one or more bases in length, And if the non-coding regions between the coding regions are unique, then each hybridized subset Equimolar amounts of the pairs are added to a single vessel. The single stranded non-coding regions hybridize and react according to the manufacturer's instructions. The fragments are ligated together using T4 DNA ligase from NEB using the protocol. If a region is more than one base long but is not unique, two adjacent hybridized sequences are The sets were added to one vessel, and the single-stranded non-coding regions were annealed and ligated with T4 DNA ligase. Once the reaction is complete, the product is optionally purified by agarose gel electrophoresis. and a third hybridized subset adjacent to one of the ends of the ligation product is added. This process continues until the construction of the library is complete. Libraries containing any number of coding regions can be constructed by this method. For present purposes, a library of over 20 coding regions is provided. Ligation may be impractical for reasons unrelated to library construction. Such translation is commonly performed by those skilled in the art, and the coding regions are linked without any intervening non-coding regions. Hybridized subset that binds to the genomic DNA but does not have non-coding regions at either end In this case, ligation provides both sense and antisense products. The product with the sequence is prepared by preparing a library and then performing all hybridization assays. By sequentially sorting on the array, the products carrying the antisense DNA are purified. The portion of the library that is captured on the array during the hybridization step is the correct sense Non-coding regions consisting only of unique restriction site sequences are an attractive option for this method. One thing will be understood.

[0251] Example 34. Constructing a gene library with corresponding 5' end coding regions. The 3'-end coding region and the 4'-end coding region may be the same building block or different building blocks. A library is constructed that encodes the same pair of block blocks for a given 5' end codon. Each member of the gene library with a coding sequence has only one 3'-end coding sequence. Such a library can be achieved by hybridizing the 5'-end coding region. Note that the subset pairs that were sized are not pooled and that the 3'-end coding regions are not pooled. All internal coding regions were pooled and constructed using the method of Example 33. Ligate as in Example 33. The ligated product of all internal coding regions is amplified. One aliquot was added to each 5'-end hybridized subset sequence. The ligation products in each well were All sequences in the genome have a single 5'-end coding sequence, excluding combinatorial mixtures of all sequences. These ligation products, which have a single 5'-end coding sequence, are The hybridized subset of sequences are transferred and ligated independently to wells containing the hybridized subset of sequences. The product contains a single 5' end coding sequence, a single 3' end coding sequence, and all internal coding sequences. A gene that contains a combinatorial mixture of all sequences in the region. It will be appreciated that there are other ways to generate libraries.

[0252] Example 35. Selection for binding to target molecules using alternative means. Binding target molecules Selection to identify potential library members was performed using IMMULON ® Plates, MAXISORP® Plates or Biological Plastic plates, like other plates commonly used for immobilizing target macromolecules, The procedure was carried out as in Example 1, except that the target molecule was immobilized on the surface of the gel or the target molecule was immobilized on the surface of the gel. and attaching the antibody to a streptavidin-coated surface or a neutravidin-coated surface, or to a magnetic beads, beads made of synthetic polymers, beads made of polysaccharides or modified polysaccharides, plate wells Immobilize the live IgG antibody on an avidin-coated surface such as a tube, resin, or other surface. Selection to identify members of the library is performed using DNA compatible and unaltered versions of any target molecule. Any suitable nucleic acid sequence that is compatible with the nucleic acid sequence and is used in a selection or amplification process. In a buffer compatible with the enzyme and compatible with identification of trait-positive library members Such buffers include those made with phosphate, citrate, and TRIS. Such buffering agents also include, but are not limited to, potassium Salts, sodium salts, ammonium salts, calcium salts, magnesium salts and other cations Salts, including chlorides, iodides, acetates, phosphates, citrates and salts of other anions. Such buffering agents include, but are not limited to, TWEEN (registered trademark). (trademark), TRITON (trademark), and Chaps (3-[(3-cholamidopropyl)dimethyl A surfactant such as 1-[4-(2-aminopropyl)-1-propanesulfonate may be included, which However, the present invention is not limited to the above.

[0253] Example 36. Selection of binders with long off-rates. Selection was carried out to Example Individuals of the library population that have the ability to bind to the target molecule as described in 1 are identified. Individuals that bind to the target molecule with a long off-rate are selected as follows. The target molecule is a bio and immobilized by incubation with a streptavidin-coated surface. or for assays such as MAXISORP® plates or ELISA No biotinylation on the plastic surface like other plates, suitable for protein binding or as described in Example 35, or by another method. Incubate the leukocyte population with fixed targets in an appropriate buffer for 0.1-8 h. The duration of the incubation is determined based on the estimated concentration of individual library members in the sample. The number of copies of the target molecule increases, and the number of copies of the target molecule increases. Higher loads may result in decreased duration. Smaller copy numbers and / or more Loading with smaller target molecules may extend the duration. The goal is to ensure that each individual in the population is able to The goal is to ensure that the library has a chance to fully interact with the target. After incubation, the binders in the library are presumed to be bound to the target. At this point, an excess of non-immobilized target is added to the system and incubation is continued for about 1 to about 24 hours. Individuals bound to the immobilized target with short off-rates are released from the immobilized target. Upon rebinding, they are distributed to bind to free and immobile targets. Any binding entities that bind to the immobilized target remain bound to the immobilized target. This allows selective removal of non-binders and binders with a fast release rate, thus allowing long-term Select individuals with off-rates. Amplification of DNA encoding long off-rate binders is carried out according to Example 1.

[0254] Example 37. Selection with moving targets. The target molecule is biotinylated and then incubated for an appropriate period of time. Selection is then performed by incubating the mixture with, for example, streptavidin. Immobilization on a vidin surface results in the immobilization of the target and the cleavage of any library bound to the target. The members are similarly immobilized. The surface is washed to remove non-binders. Amplification of the DNA encoding the binder is carried out according to Example 1.

[0255] Example 38. Selection for target specificity. Selection is performed by selecting a desired target molecule to the exclusion of other anti-target molecules. This is done to identify individuals in the library population that bind to the anti-target molecule. le) (or molecules, if multiple molecules are present) are biotinylated and Immobilized on an avidin-coated surface or on a MAXISORP® plate or some other suitable for protein binding for assays such as ELISA. In a separate container, the target molecule is immobilized on a plastic surface such as a plate. The antibodies were then immobilized by incubating them on a streptavidin-coated surface. or assays such as MAXISORP® plates or ELISA For protein binding, some other plates are suitable for plastic surfaces. The library is first incubated with the anti-target. This is done by immobilizing the anti-target molecule. After this incubation with the anti-target, the library The cells are transferred to a vessel containing the desired target and incubated for an appropriate period of time. Amplification of DNA encoding long off-rate binders is shown in Example 1. The identified target binders are modified to selectively bind the target to the anti-target. Optionally, affinity selection for the target can be performed by immobilizing the target and free The mobilizable anti-target is added in excess, followed by the library, and incubated for an appropriate period of time. In this situation, individuals with affinity for the anti-target are Since it is present in excess, it is preferentially bound by the anti-target and is therefore removed during washing of the surface. Amplification of the DNA encoding the binder is carried out according to Example 1.

[0256] Example 39: Selection based on differential mobility. Selection is performed by detecting the target molecule or a polymacromolecule. romolecular structures are formed when interacting with library members. Based on the difference in mobility of the library members in the complex, the target molecule or the multi-polymer structure can be identified. The method is based on the ability of individuals in the library population to interact with the target molecule or allows interaction of the structures with library members, and then the mixture is mixed with a size exclusion medium By passing the library members through the target molecule or structure, the library members that do not interact with the target molecule or structure are are physically separated from the interacting library members because A complex of a library member and a target molecule or structure that interacts with a non-interacting library member is The beam will be larger than the bar and will therefore move through a medium with different mobility. The difference in mobility is a function of diffusion in the absence of a size exclusion medium, and mobility is a function of gravity flow, electrochemical flow, and This can be induced by a variety of means, including, but not limited to, electrophoresis and diffusion. It is understood that.

[0257] Example 40. General strategy for other selections. The assay comprises: (a) selecting a library population; In this case, individuals that have the desired property are physically separated from those that do not, or (b) determining whether or not a DNA encoding an individual of the library population has a desired characteristic is a DNA sequence encoding the individual. Either the DNA encoding the library members that do not have the If the design is one way or the other, selection can be made for almost any characteristic. As will be appreciated by those of skill in the art, many methods of immobilizing target molecules are known to those of skill in the art. The target molecule is tagged with a His tag and immobilized on a nickel surface. and immobilize with anti-Flag antibody, or tag the target molecule with a linker and immobilize with anti-Flag antibody. , covalently immobilizing the library members on a surface. The sequence of events that allows the target to be immobilized depends on the immobilization method used. It will be understood that this may be done in a variety of orders as dictated by law or as may become available. Selection should be performed that does not require immobilization or physical separation of trait-positive from trait-negative individuals. For example, a trait-positive individual may be considered to have a DN in the absence of a trait-negative individual. Recruit factors that allow amplification of A. Trait-positive individuals are tagged with PCR primers. However, trait-negative individuals are not tagged. Any process that specifically amplifies trait-positive individuals The material is suitable for use.

[0258] Example 41a. Chemical reactions for charging reactive site adaptors. It is understood that any of the above chemistries are suitable for use in charging the reactive site adaptors. The reactive site adaptor can be in an aqueous solution, in an aqueous / organic mixture, or immobilized on a solid support. The reactive site adapter is charged with the building block. The chemistry used to charge the carboxylates is that the reactive site adapter is DEAE or Super It is not limited to reactions carried out while immobilized on a solid support such as Q650M. Nor is it limited to reactions carried out in solution phase.

[0259] Example 41b. Absence of a building block is a codable diversity element During the library synthesis, the sequence of the various library subpools with different sequences is determined. Diversity occurs when multiple building blocks are introduced independently into a system. The absence of a building block is an optional diversity element. The absence of one or more sequence-specific subgroups of the library in a desired chemical process Except that the polymer is not subjected to chemical reactions to introduce building blocks. The sequences of the subpools are coded exactly as in Example 1. In such a case, the sequences of the subpools are thus Codes for the absence of a building block.

[0260] Example 42. Hybridization arrays contained other materials. Localization arrays can accomplish two important tasks: (a) sequence-specific hybridization; To sort a heterogeneous mixture of at least partially single-stranded DNA through DNA redistribution. and (b) the array allows for the sorted subpools to be removed independently from the array. The array on which the anticode oligonucleotides are immobilized may be The features of can be oriented in any 3D direction that satisfies the above criteria, but A rectangular grid array of 3D dimensions is already used in many commercially available experimental instruments. Since they are mass-produced in bulk (e.g., 96-well plates, 384-well plates), It's currently the most attractive.

[0261] The solid support in the array feature on which the anticode oligos are immobilized is 4 This can accomplish two tasks: (a) Permanently attaching the anticode oligos (b) by sequence-specific hybridization to immobilized oligos. (c) library DNA that allows or is capable of being captured; A can have low background or nonspecific binding, and (d) can be used at high pH It may be chemically stable to the processing conditions, including the steps performed. PHAROSE® is a combination of azide-PEG-amine and CM SEPHAR By peptide bond formation between carboxyl groups on the surface of OSE® resin It is functionalized with a di-PEG-amine (containing 9 PEG units). Anticode oligos bearing the decorators were synthesized by copper-mediated 1,3-dipolar cycloaddition (Huisgen) It is "clicked" to the azide in

[0262] Other suitable solid supports include hydrophilic beads, or solid supports having a hydrophilic surface coating. Polystyrene beads, polymethylmethacrylate beads with hydrophilic surface coating , and hydrophilic surfaces that also have reactive functional groups such as carboxylates, amines, or epoxides. Other beads having appropriately functionalized anticode oligos immobilized thereon can be mentioned. Other suitable supports include monoliths and hydrogels. See, e.g., J Chro matogr A.2002 Jun 14;959(l-2):121-9,J Ch romatogr A.2011 Apr 29;1218(17):2362-7,J Chromatogr A.2011 Dec 9;1218(49):8897-9 02,Trends in Microbiology,Volume 16,Issu e 11,543-551,J.Polym.Sci.A Polym.Chem,35 :1013-1021,J.Mol.Recognit.2006;19:305-31 2, J. Sep. Sci. 2004, 27, 828-836. In general, the larger Solid supports with larger surface areas capture larger amounts of library DNA and have smaller Beads with a diameter of 100 mm or less create much higher back pressure and flow resistance. These limitations are due to the surface Partially improved by the use of porous supports or hydrogels with very high volume but low back pressure In general, positively charged beads tend to bind DNA to a greater extent than nonspecifically charged beads. do.

[0263] The hybridization array chassis can accomplish three tasks: a) physical separation between features must be maintained, and (b) libraries must be Allowing or causing a char to flow over or through a feature ( c) Ability to remove library DNA that is independently selected from different features The chassis must be sufficiently rigid and chemically stable under processing conditions. Any material compatible with any means required to secure the support within the feature. Typical chassis materials include DELRIN (registered trademark), TECAFROM (registered trademark), Plastics such as polyether ether ketone (PEEK), ceramics, These include metals such as aluminum and stainless steel.

[0264] Example 43. Gene library parameters. The gene library is comprised of 2 to 20 The number of available coding sequences in each internal coding region is determined by the available Limited only by the number of features with fixed anticode sequences. Industry standard consumable laboratory equipment available in 4-well, 96-well, and 384-well formats Since there are always many more, it is convenient to use these number of coding sequences in the coding region, e.g. Coding regions with 768 or 1536 coding sequences may also be useful. Because sequences are not sorted on the array, the number of sequences used in the terminal coding regions is based on industry standard This reduces the need to accommodate the number of wells in standard plates and lab equipment. It may be practical to use 96 or even 960 or more different coding sequences in the coding region.

Claims

1. A probe molecule, the probe molecule having formula (I): (I) ([(B 1 ) M -D-L 1 ] Y -H 1 ) O -G-(H 2 -[L 2 -E-(B 2 ) K ] W ) P According to this, G is an oligonucleotide, said oligonucleotide comprising at least two coding regions encoding a positional building block and at least one terminal coding region encoding a first building block or a second building block, said at least two coding regions being single stranded, and said at least one terminal coding region being single stranded or double stranded; H 1 is a hairpin structure comprising an oligonucleotide comprising a loop portion, a stem portion and a 5' single stranded portion, 1 comprises a 5' end which is complementary to the end of said oligonucleotide G; H 2 is a hairpin structure comprising an oligonucleotide comprising a loop portion, a stem portion and a 3′ single-stranded portion, 2 comprises a 3' terminus which is complementary to the terminus of said oligonucleotide G; D is the first building block; E is the second building block, D and E are the same or different; B 1 is a positional building block, M represents an integer from 1 to 20; B 2 is a position building block, K represents an integer from 1 to 20, B 1 and B 2 are the same or different, M and K are the same or different; L 1 H 1 is a linker operably linking L 2 H 2 is a linker operably linking O is an integer from 0 to 1; P is an integer from 0 to 1; With the proviso that at least one of O and P is 1; When the value of O is 1, Y is an integer from 1 to 5; When the value of P is 1, W is an integer from 1 to 5; B at position M 1 and B at position K 2 at least one of each position building block is identified by one of the at least two coding regions, and at least one of the first building block D and the second building block E is identified by the at least one terminal coding region; H 1 Or H 2 at least one of the following sequences contains a unique restriction site or at least one deoxyuridine (dU) base; Probe molecules.

2. B 1 The probe molecule of claim 1 , wherein the building blocks at multiple positions in the

3. B 2 The probe molecule of claim 1 or 2, wherein the building blocks at multiple positions in the

4. L 1 D to H 1 and / or L 2 E to H 2 covalently binds to the loop portion or the stem portion of The probe molecule according to any one of claims 1 to 3.

5. G is a compound represented by the formula (C N - (Z N -C N+1 ) A wherein C is a coding region, Z is a non-coding region, N is an integer from 1 to 20, and A is an integer from 1 to 20; Each non-coding region comprises 4 to 50 nucleotides; The probe molecule according to any one of claims 1 to 4.

6. The probe molecule of claim 5 , wherein each non-coding region is double-stranded.

7. The probe molecule according to any one of claims 1 to 6, wherein one of O or P is zero.

8. The probe molecule according to any one of claims 1 to 7, wherein at least one of Y and W is an integer of 1 or 2.

9. H 1 and H 2 The probe molecule according to any one of claims 1 to 8, wherein at least one of the following comprises 20 to 90 nucleotides.

10. The probe molecule according to any one of claims 1 to 9, wherein each coding region comprises from 6 to 50 nucleotides.

11. The probe molecule according to any one of claims 1 to 10, wherein each coding region comprises from 12 to 40 nucleotides.

12. P is zero and Y is an integer from 1 to 2, and each coding region contains from 12 to 40 nucleotides; or O is zero, W is an integer from 1 to 2, and each coding region contains from 12 to 40 nucleotides; The probe molecule according to any one of claims 1 to 11.

13. P is zero, Y is 2, and each coding region contains from 12 to 40 nucleotides; or O is zero, W is 2, and each coding region contains 12 to 40 nucleotides; The probe molecule according to any one of claims 1 to 12.

14. The probe molecule according to any one of claims 1 to 11, wherein at least one of Y or W is at least 2, and / or O and P are both 1.

15. The probe molecule according to any one of claims 1 to 11 and 14, wherein O and P are both 1.

16. H of the probe molecule 1 Or H 2 The probe molecule according to any one of claims 1 to 15, wherein said unique restriction site is

17. H of the probe molecule 1 and H 2 The probe molecule according to any one of claims 1 to 15, wherein at least one of the following comprises at least one dU base:

18. A method for analyzing a probe molecule according to claim 16, comprising the steps of: treating said probe molecule with a restriction enzyme that recognizes said unique restriction site; performing a polymerase chain reaction (PCR) on the treated probe molecules, thereby generating a PCR product; sequencing the PCR products; and analyzing the sequence of the PCR product to identify the positional building blocks. A method comprising:

19. 20. A method for analyzing a probe molecule according to claim 17, comprising the steps of: treating the probe molecule with uracil DNA glycosylase; performing a polymerase chain reaction (PCR) on the treated probe molecules, thereby generating a PCR product; sequencing the PCR products; and analyzing the sequence of the PCR product to identify the positional building blocks. A method comprising:

Citation Information

Patent Citations

  • Methods for Synthesis of Encoded Libraries

    JP2007524662A

  • Method for constructing and screening DNA-coding libraries

    JP2012517812A

  • Methods for synthesis of encoded libraries

    US20120245040A1

  • Methods of synthesis of oligonucleotide tagged combinatorial libraries and uses thereof

    US20150344872A1